Locking assembly for coupling guidewire to delivery system

Description

BACKGROUND
Technical Field

The present disclosure relates to devices and methods for reversibly coupling a guidewire or other elongate structure to a delivery system.

Description of the Related Art

Some surgical procedures require multiple guidewires, for example to facilitate delivery of an implant to a branched vessel or maintain access in a branched vessel. During these procedures, an implant can be delivered via a delivery system through a first branch vessel (e.g., ipsilateral iliac artery) and access can be provided through a second branch vessel (e.g., contralateral iliac artery) using a catheter, guidewire, or otherwise. However, existing techniques for providing access to the branch vessel involve many steps and may increase the size of the delivery system, thus making the procedure more difficult to perform.

SUMMARY

Certain embodiments described herein are directed to systems, methods and apparatuses for treating endovascular aneurysms or other endovascular defects. However, it will be appreciated that the systems, methods and apparatuses may have application to other fields. In some embodiments, the defects being treated may include, but are not limited to, abdominal aortic aneurysms, subclavian aneurysms, and thoracic aortic aneurysms, to name a few.

As mentioned above, certain surgical procedures, such as those for treating aortic aneurysms may involve the use of multiple guidewires to maintain access through multiple vessels. However, managing multiple guidewires can be difficult, for example because a contralateral guidewire may be inadvertently withdrawn when a sheath or other tubular structure is withdrawn over the contralateral guidewire. Existing systems may utilize a hollow guidewire or other tubular structure to couple a contralateral portion of the delivery system to an ipsilateral portion of the delivery system or to facilitate advancement of a contralateral guidewire to the target vessel. However, the hollow guidewire or other elongate structure increases a diameter of the contralateral portion of the delivery system and increases the number of steps involved in providing and/or removing contralateral access. Thus, it may be desirable to provide a delivery system in which the contralateral guidewire is directly secured to the ipsilateral portion of the delivery system to both reduce the diameter of the contralateral portion of the delivery system and/or reduce the number of steps to provide and/or remove contralateral access. Reducing the diameter of the contralateral portion reduces the size of the contralateral access.

Other devices and techniques use gate cannulation to access the contralateral limb of the stent graft above the bifurcation, which can be challenging and time consuming. Certain aspects of the present disclosure allow for easier deployment of the contralateral limb by providing a precannulated stent graft through the contralateral limb. The present disclosure can also allow the use of a larger guidewire (e.g., 0.035 in.). Precannulation of the contralateral limb eliminates gate cannulation, thereby simplifying the graft placement procedure.

Certain aspects of this disclosure are directed toward a locking assembly for releasably coupling a guidewire to a delivery catheter such that the guidewire can be released from the delivery catheter. In certain aspects of the locking assembly herein, a housing has a proximal end, a distal end, and a lateral wall portion. A recess extends at least partially through the lateral wall of the housing. A first lumen extends from the proximal end of the housing to the distal end of the housing along a longitudinal axis. A second lumen extends from the distal end of the housing, the diameter of the second lumen being less than the diameter of the first lumen. The second lumen is configured to receive and retain a guidewire.

Optionally, the locking assembly includes an elastomeric member that is retained in the recess. The elastomeric member can be configured to retain the guidewire when the guidewire extends into the second lumen. At least a portion of the elastomeric member can be substantially flush with an outer surface of the lateral wall of the housing. The elastomeric member can have an opening that at least partially aligns with the second lumen. The opening of the elastomeric member can have a diameter that is smaller than the diameter of the second lumen of the locking assembly to help retain a guidewire extending through the second lumen.

In certain aspects, the locking assembly has a protruding portion extending along at least a portion of the outer periphery of a distal portion of the housing to provide strain relief to the guidewire that extends distally from the second lumen. The second lumen can be positioned between the first lumen and the protruding portion.

Certain aspects of the present disclosure are directed toward a system utilizing the above-described locking assembly. The locking assembly can be fixed to a first elongate member. The system can also include a second elongate member configured to be retained by the second lumen alone or the second lumen in combination with the elastomeric member.

Certain aspects of the disclosure are directed toward a locking assembly that couples a contralateral guidewire to an ipsilateral catheter. The locking assembly has an anchoring portion configured to engage the ipsilateral catheter. The locking assembly has an interlock portion configured to retain a distal portion of the contralateral guidewire when the contralateral guidewire is advanced or retracted unless a vertical force between about 0.01 and about 6.0 lbf (e.g., between about 0.01 and about 0.5 lbf, between about 0.25 and about 0.75 lbf, between about 0.5 lbf and about 1.0 lbf, between about 0.75 lbf and about 1.15 lbf, between about 1.0 lbf and about 2.0 lbf, between about 1.5 lbf and about 2.5 lbf, between about 2.0 lbf and about 3.0 lbf, between about 2.5 lbf and about 3.5 lbf, between about 3.0 lbf and about 4.0 lbf, between about 3.5 lbf and about 4.5 lbf, between about 4.0 lbf and about 5.0 lbf, between about 4.5 lbf and about 5.5 lbf, or between about 5.0 lbf and about 6.0 lbf, or otherwise) is applied to the contralateral guidewire.

Certain aspects of the present disclosure are directed toward a method of using the locking assembly described above. The method can include advancing a delivery system in a locked configuration. The delivery system can include a locking assembly fixed to the ipsilateral catheter. The locking assembly can include an interlock portion configured to retain the guidewire when the delivery system is in the locked configuration. A distal end of the guidewire can be introduced into the interlock portion from a distal side of the locking assembly such that the guidewire has a bend when the delivery system is in the locked configuration. The bend can be positioned between a proximal portion of the guidewire and the distal portion of the guidewire. The method can also include releasing the delivery system from the locked configuration to the unlocked configuration by advancing a release catheter along the guidewire.

BRIEF DESCRIPTION OF THE DRAWINGS

These and other features, aspects and advantages will now be described in connection with certain embodiments, in reference to the accompanying drawings. The illustrated embodiments, however, are merely examples and are not intended to be limiting. The following are brief descriptions of the drawings.

FIG. 1A is a schematic representation of a bifurcated vascular prosthesis for use with the present disclosure, positioned at the bifurcation between the abdominal aorta and the right and left common iliac arteries.

FIG. 1B is an exploded view of a bifurcated graft for use with the present disclosure, showing a self-expanding wire support cage separated from an outer polymeric sleeve.

FIG. 2 is a schematic representation of an embodiment of the deployment catheter for delivering a bifurcated prosthesis, with a proximal portion of the main branch portion of the graft at least partially deployed.

FIG. 3 is a cross-sectional view of an embodiment of a deployment catheter for delivering a bifurcated prosthesis.

FIG. 4 is an enlargement of the portion delineated by curve 4-4 in FIG. 3.

FIG. 5 is a cross-sectional view of the embodiment of the deployment catheter shown in FIG. 3 taken along line 5-5 of FIG. 4.

FIG. 6 is a cross-sectional view of the embodiment of the deployment catheter shown in FIG. 3 taken along line 6-6 of FIG. 4.

FIG. 7 is a schematic representation of an embodiment of the deployment catheter with the guidewire sheath positioned across the bifurcation.

FIG. 8 is a schematic representation, as in FIG. 7, with the deployment catheter positioned in the aorta.

FIG. 9 is a schematic representation, as in FIG. 8, with the compressed iliac branches of the graft positioned partly within the iliac arteries.

FIG. 10 is a schematic representation, as in FIG. 9, with a proximal portion of the main branch portion of the graft at least partially deployed within the aorta.

FIG. 11 is a schematic representation, as in FIG. 10, following the further proximal retraction of the guidewire sheath and the contralateral branch sheath through the contralateral iliac artery, causing the deployment of the contralateral branch portion of the graft.

FIG. 12A is a schematic representation, as in FIG. 11, following the proximal retraction of the ipsilateral branch sheath and deployment of the ipsilateral branch portion of the graft.

FIG. 12B is a schematic representation, as in FIG. 12A, following introduction of the release member at the contralateral access site and advancement of the release member along the contralateral guidewire.

FIG. 12C is a schematic representation, as in FIG. 12B, with a release member interfacing with a locking assembly.

FIG. 12D is a schematic representation, as in FIG. 12C, with a release member being retracted through the contralateral access site following decoupling of the contralateral guidewire from a locking assembly. In some embodiments, a cuff may be implanted (e.g., on a proximal end of the main branch portion) to secure or lengthen the graft.

FIG. 13A is a schematic representation of a locking assembly configured to releasably retain an elongate member.

FIG. 13B is an isometric view of an exemplary embodiment of the locking assembly including a housing an elastomeric member.

FIG. 14 is an isometric view of an embodiment of the elastomeric member shown in FIG. 13B.

FIG. 14A is a top view of an embodiment of the elastomeric member shown in FIG. 14.

FIG. 14B is a rear view of an embodiment of the elastomeric member shown in FIG. 14.

FIG. 14C is a front cross-sectional view of an embodiment of the elastomeric member shown in FIG. 14.

FIG. 14D is a front view of an embodiment of the elastomeric member shown in FIG. 14.

FIG. 15 is a front cross-sectional view of an embodiment of the present locking assembly.

FIG. 16 is a front cross-sectional view of an alternative embodiment of the present locking assembly.

FIG. 17A is a front view of an embodiment of a locking assembly coupled to a contralateral guidewire.

FIG. 17B is a front view of the embodiment depicted in FIG. 17A interfacing with a release member.

FIG. 18A is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18B is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18C is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18D is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18E is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18F is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18G is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18H is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18I is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18J is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18K is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18L is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18M is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18N is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18O is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18P is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18Q is an alternative embodiment of the locking assembly presently disclosed.

FIG. 18R is an alternative embodiment of the locking assembly presently disclosed.

FIG. 19 is a side view of an embodiment of a contralateral guidewire.

DETAILED DESCRIPTION

The following detailed description is now directed to certain specific embodiments of the disclosure. In this description, reference is made to the figures wherein like parts are designated with like numerals throughout the description and the drawings. Described below are various embodiments of a delivery system for establishing a surgical platform having multiple guidewires. In some aspects, the present disclosure is directed to devices and methods for deploying a vascular graft for treatment of an abdominal aortic aneurysm, including a deployment catheter and a guidewire assembly which may be used to maintain access through an implanted vascular graft for subsequent catheterizations.

An abdominal aortic aneurysm usually arises in the infrarenal portion of the diseased aorta, for example, below the kidneys. The aneurysm often occurs near a site of vessel branching, making a bifurcated stent a well-suited device for treating the abdominal aortic aneurysm. Endoluminal implantation is an increasingly accepted technique for implanting vascular grafts. This procedure may involve femoral cut down access or percutaneously inserting a vascular graft or prosthesis by using a delivery catheter. This process eliminates the need for major surgical intervention, thereby decreasing the risks associated with vascular and arterial surgery. Various embodiments of catheter delivery systems for prosthetic devices are described herein.

Endovascular surgical procedures can use a guidewire to help position a catheter or place prosthesis. Guidewires can provide a surgical platform from which a physician can conduct a minimally-invasive medical procedure. In some instances, a physician may use multiple guidewires in a medical procedure. When multiple guidewires are used, a first guidewire may have at least one of its ends in a location that is different from at least one of the ends of a second guidewire. When multiple guidewires are used, at least a portion of a first guidewire may be located in proximity to at least a portion of a second guidewire. In some instances, one end of a first guidewire may be located next to a portion of a second guidewire while the other end of the first guidewire is at a location different from the location of the end of the second guidewire. A first guidewire may access the patient at one location and be joined within the patient to a second guidewire that accesses the patient from a different location. Guidewires that access the patient's body from different locations can be used to deploy a bifurcated stent, to seat a heart valve, or to perform an endovascular surgical procedure.

Certain current delivery systems for a bifurcated stent graft system or a graft having at least one branch portion may use two separate sheaths to deploy the distal segment of the graft before the proximal segment. The outer sheath is first retracted to deploy a portion of the mid-body and the contralateral limb. Then, the front sheath is advanced distally to deploy the distal end of the graft. See e.g., U.S. Pat. No. 6,660,030. Other delivery systems, for example as disclosed in U.S. patent application Ser. No. 11/522,292, titled “A MULTI-SEGMENTED GRAFT DEPLOYMENT SYSTEM” and filed on Sep. 15, 2006 (the entirety of which is hereby incorporated by reference as if fully set forth herein) may use a plurality of axially spaced releasable restraint members temporarily connected by a pull wire to allow the distal main branch portion to be deployed before a proximal graft portion. Typically, these delivery systems are delivered to the aneurysm location over a guidewire. The guidewire may be further used to release a branch graft portion of the prosthesis, for example, by operably connecting a branch graft restraint mechanism to the guidewire and proximally withdrawing the guidewire from the vasculature.

Once the bifurcation graft has been deployed and implanted, a variety of procedures may desirably be accomplished. For example, it may be advantageous to implant a cuff (e.g., on the proximal end of the main branch portion) to secure the graft and thereby prevent movement or slippage of the main branch portion. Alternatively, it may be necessary to dilate the stenosis or touch up or re-establish the expansion of the graft. These procedures require advancing another catheter to the graft location along a guidewire. However, the positioning of a guidewire through the graft after the graft has been deployed is difficult since the tip of the guidewire may snag on the wire support cage of the graft. Thus, it may be advantageous to provide a guidewire assembly configured to remain placed through a graft once the graft has been deployed and to allow access through the expanded graft for subsequent catheterizations. Additionally, it may be advantageous to improve the configuration of the deployment catheter and/or the graft restraining members so as to improve the methods of deploying and positioning bifurcated and non-bifurcated grafts, as will be described herein.

In certain embodiments, the deployment catheter may be configured to deliver a graft that includes a main or distal graft portion and at least one branch or proximal graft portion. In certain embodiments, the hollow guidewire assembly may be associated with a restraint member for the branch segment, such that the branch segment may be deployed by the guidewire assembly. The guidewire assembly may be further configured such that it may be used to remove the restraint member from the branch segment while permitting placement and maintenance of a guidewire through the expanded branch segment and main body graft for subsequent catheterizations. Other embodiments of a graft deployment system and guidewire assembly will also be described below.

Prosthesis

FIG. 1A is a schematic representation of an example of a bifurcated vascular graft 50 that can be used with any embodiment of the deployment catheter disclosed herein, positioned at the bifurcation between the abdominal aorta 30 and the right and left common iliac arteries 37 and 38. With reference to FIG. 1A, there is illustrated a schematic representation of the abdominal part of the aorta and its principal branches. In particular, the abdominal aorta 30 is characterized by a right renal artery 2 and left renal artery 4. The large terminal branches of the aorta 30 are the right and left common iliac arteries 37 and 38. Additional vessels (e.g., second lumbar, testicular, inferior mesenteric, middle sacral) have been omitted from FIG. 1A for simplification. One embodiment of an expanded bifurcated endoluminal vascular prosthesis is shown spanning aneurysms 103, 104 and 105. The expanded bifurcated endoluminal vascular graft 50 can comprise a main branch portion 52 (also referred to herein as a main branch segment) for traversing the aorta, a first branch portion 54 (also referred to herein as a first branch segment or an ipsilateral branch portion) for spanning an ipsilateral iliac artery 37, and a second branch portion 56 (also referred to herein as a second branch segment or a contralateral branch portion) for spanning a contralateral iliac artery 38.

The terms “first” and “second” may be used interchangeably. In one embodiment, the first branch portion can refer to a downstream or upstream portion of a main branch vessel. For example, in one embodiment, the main branch portion and the first branch portion are configured to lie within at least a portion aortic arch (including, for example, the ascending and/or descending aorta) with main branch portion positioned closer to the heart while the second branch portion can be configured to extend into one of the branch vessels (left subclavian, right subclavian or carotid) that extend from the aortic arch.

FIG. 1B is an exploded view of the bifurcated graft 50 of FIG. 1A, which can include a self-expanding wire support cage 60 and an outer polymeric sleeve 68. In FIG. 1B, the wire support 60 is shown separated from an outer polymeric sleeve 68. In the illustrated embodiment, the polymeric sleeve 68 can be situated concentrically outside of the tubular wire support 60. However, other embodiments may include a sleeve positioned instead concentrically inside the wire support or positioned on both the inside and the outside of the wire support. Alternatively, the wire support may be embedded within a polymeric matrix or layer which makes up the sleeve. The sleeve 68 may be attached to the wire support 60 by any of a variety of suitable manners known to those skilled in the art.

The tubular wire support 60 can comprise a main branch portion 62 for traversing the aorta, a first branch portion 64 (also referred to herein as an ipsilateral branch portion) for spanning an ipsilateral iliac and a second branch portion 66 (also referred to herein as a contralateral branch portion) for spanning a contralateral iliac. The main branch portion 62 and first ipsilateral branch portion 64 can be formed from a continuous single length of wire having a proximal end, a distal end and a central lumen extending therebetween. Alternatively, the first ipsilateral branch portion 64 may be formed of one or more lengths of wire pivotably connected to the proximal end of the main branch portion 62. A second, contralateral branch component 66 may be formed of one or more lengths of wire pivotably connected to the proximal end of the main branch portion 62. Each of the iliac branch components has a proximal end, a distal end and a central lumen extending therethrough. Construction of the graft from a three part cage conveniently facilitates the use of different gauge wire in the different components (e.g. 0.014 in. diameter main trunk and 0.012 in. diameter branch components).

In general, each of the components of the bifurcated endoluminal vascular graft 50 may vary considerably in diameter, length, expansion coefficient, and other parameters or characteristics, depending upon the intended application. For implantation within the aorta of a typical adult, the main branch portion 52 will have a length within the range of from approximately 2 in. or less to approximately 5 in. or more, and, typically within the range of from approximately 3.5 in. to approximately 4 in. The unconstrained outside expanded diameter of the main branch portion 52 will typically be within the range of from approximately 0.75 in. to approximately 1.5 in. The unconstrained expanded outside diameter of the main branch portion 52 can be constant or substantially constant throughout the length, or can be tapered from a relatively larger diameter at the distal end to a relatively smaller diameter at the bifurcation. In general, the diameter of the proximal end of the main branch portion will be on the order of no more than approximately 95% and often no more than approximately 85% of the diameter of the distal end of the main branch portion. The iliac branch portions 54 and 56 will typically be bilaterally symmetrical, having a length within the range of from approximately 0.4 in. to approximately 2.6 in., and a diameter within the range of from approximately 0.04 in. to approximately 0.79 in.

The collapsed prosthesis for use in accordance with the present disclosure has a diameter in the range of approximately 0.08 in. to approximately 0.39 in. The maximum diameter of the collapsed prosthesis can be in the range of approximately 0.12 in. to approximately 0.24 in. (12 to 18 French). Some embodiments of the deployment catheter, including the prosthesis, can have a diameter in the range of from approximately 18 to approximately 20 or approximately 21 French. Other embodiments can have a diameter as low as approximately 19 French, approximately 16 French, approximately 14 French, or smaller. After deployment, the expanded endoluminal vascular prosthesis may radially self-expand to a diameter anywhere in the range of approximately 0.8 in. to approximately 1.6 in.

Although certain prosthesis configurations are disclosed herein, these are only examples of prostheses which are deployable using the embodiments of a deployment catheter and guidewire assembly described herein. In other embodiments, the delivery system described below may be used to deliver and deploy other types of self-expandable bifurcated or multi-segmented prosthesis having a main branch portion and at least one branch graft portion, as will be apparent to those of skill in the art in view of the disclosure herein. For example, in other embodiments, certain features and aspects of the deployment catheter and guidewire assembly can be used to deploy a graft without a branch graft portion, a graft with only one branch portion and/or a graft with more than one graft portions. Further details and additional embodiments of the prosthesis described above can be found in U.S. Pat. Nos. 6,007,296, 6,187,036, and 6,197,049, the entirety of each of which is hereby incorporated by reference herein.

It should also be appreciated that, although the illustrated embodiments are described in the context of a bifurcated graft configured for the abdominal aorta, certain features and aspects of the delivery systems and methods described herein can be used in other portions of the vascular system. For example, it is anticipated that certain features and aspects of the systems and methods described herein can be adapted for use in the thoracic aorta. In some embodiments, the deployment catheter 120 (see FIG. 3) may be configured to treat defects that may include, but are not limited to, abdominal aortic aneurysms, subclavian aneurysms, and thoracic aortic aneurysms, to name a few. It is also anticipated that certain features and aspects of the system described herein may be adapted to deliver a single straight graft segment to the thoracic aorta or other vessels or arteries within the body.

Delivery System

The expandable bifurcation graft 50 can be deployed at a treatment site with any of a variety of deployment catheters, as will be apparent to those of skill in the art. Any of the embodiments of the deployment catheters disclosed herein may comprise any of the materials, features, or other details of any deployment catheters suitable for deploying an expandable bifurcation graft known in the field. Further details and additional embodiments of the deployment catheter can be found in U.S. Pat. Nos. 8,236,040 and 8,523,931, the entirety of each of which is hereby incorporated by reference herein.

The deployment catheters herein disclosed can be used for deploying a self-expanding bifurcation graft known in the field, or in any of the embodiments disclosed in U.S. Pat. Nos. 6,090,128, 6,500,202, 6,660,030, 8,523,931, and U.S. Pat. Pub. 2008/0071343. The entirety of each of the above-referenced patents and published patent applications is hereby incorporated by reference in their entirety as if fully set forth herein.

With reference to FIG. 2, one method for using an embodiment of a deployment catheter 120 for treating an abdominal aortic aneurysm will be briefly described, without limitation. More detail regarding this deployment method will be described below. FIG. 2 is a schematic representation of an embodiment of a deployment catheter 120 for delivering a bifurcated prosthesis or graft 50, showing a proximal portion of the main branch portion 52 of the graft 50 at least partially deployed within the aorta for illustration purposes. As shown in FIG. 2, the deployment catheter 120 can be introduced into a patient's vasculature through a puncture site in the patient's ipsilateral artery. The deployment catheter 120 is not limited to treatment of an abdominal aortic aneurysm; it can be configured to treat other aneurysms as discussed more fully herein. Additionally, depending on the clinical requirements, the deployment catheter 120 can be introduced into the patient's vasculature through puncture sites other than an ipsilateral artery. For example, without limitation, the deployment catheter 120 can be introduced into the patient's vasculature through a contralateral artery, through a radial artery, or through a subclavian artery.

As illustrated in FIG. 2, the deployment catheter 120 can be advanced over a guidewire 226 to the desired location within the patient's aorta. The graft 50 illustrated in FIG. 2 can include a main branch portion 52 constrained within a main branch sheath or member 186, an ipsilateral branch portion 54 constrained within and ipsilateral branch sheath or member 188, and a contralateral branch portion 56 constrained within a contralateral branch sheath or member 190. Prior to the deployment of the main branch portion 52 of the graft 50 as shown in FIG. 2, the entire graft can be constrained within an outer sheath 128 of the deployment catheter 120. In brief, the graft 50 can be exposed by retracting the outer sheath 128, and the deployment catheter 120 can be manipulated so as to position the contralateral branch portion 56 in the contralateral artery 38.

After positioning the graft 50 in the desired position, illustrated in FIG. 2, the main branch portion 52 of the graft 50 can be deployed by retracting a sheath release 166 (e.g., a cord, suture, wire, or likewise), which can cause the perforated main branch sheath 186 to tear along a side thereof. The remaining portion of the main branch portion 52 can be deployed by further withdrawing the sheath release 166. The main branch sheath 186 can be attached to the sheath release 166, allowing the main branch sheath 186 to be removed through the ipsilateral access site as the sheath release 166 is removed through the ipsilateral access site. In other configurations, the main branch sheath 186 can be separately withdrawn from the contralateral access site or with either the ipsilateral branch sheath 188 or the contralateral branch sheath 190.

In the illustrated embodiment, the contralateral branch portion 56 of the graft 50 can be deployed by withdrawing a contralateral guidewire sheath 216 through a puncture site in the contralateral iliac artery 38, causing the contralateral branch sheath 190 to be withdrawn. Similarly, the ipsilateral branch portion 54 of the graft 50 can be deployed by withdrawing the deployment catheter 120 through a puncture site in the ipsilateral iliac artery 37, causing the ipsilateral branch sheath 188 to be withdrawn either before or after the contralateral branch sheath 190 is withdrawn.

The deployment method described with reference to FIG. 2 is not intended to limit the applicability of the deployment catheter 120. The deployment catheter 120 may be configured to deploy a straight, bifurcated, or any other graft configuration into any portion of an artery or other blood vessel in the body. In some embodiments, the deployment catheter 120 may be used to deploy grafts having anchoring elements that help secure the graft to the vessel wall as well as grafts that do not have anchoring elements. With this brief, non-limiting overview of one method of using the deployment catheter 120 having been described, additional features and configurations of the deployment catheter 120 and additional details of this and other deployment methods will now be described.

FIG. 3 is a cut-away side view of a non-limiting exemplary embodiment of a deployment catheter 120. The inner core 132 of the deployment catheter 120 can include a guidewire lumen 154 and a sheath release lumen 156 extending longitudinally therethrough. The guidewire lumen 154 can be defined by a central tube 170 that can be disposed within inner core 132. The guidewire lumen 154 can be defined by a hole bored along a longitudinal axis of the inner core 132. In the illustrated embodiment, the guidewire lumen 154 can extend throughout the entire length of the tubular inner core 132, having a distal exit port 158 and a proximal access port 160, as will be understood by those of skill in the art. In use, the deployment catheter 120 can be advanced into position in the aorta over a guidewire 226 (shown in FIG. 2) extending through the guidewire lumen 154, as will be understood by those of skill in the art. A sheath release 166 (also may be referred to herein as a cord) can be routed through the sheath release lumen 156. In the illustrated embodiment, the sheath release lumen 156 can extend through the entire length of the tubular inner core 132, having a distal exit port 162 and a proximal access port 164, as will be understood by those of skill in the art.

In the embodiment of the deployment catheter 120, the guidewire lumen 154 can be co-planar with the centerline axis of the inner core 132 and the sheath release lumen 156. However, this arrangement is not required. In some embodiments, the guidewire lumen 154 can be not coplanar with the centerline axis of the inner core 132 and the sheath release lumen 156. Therefore, the inner core 132 may be configured so that the guidewire lumen 154 and the sheath release lumen 156 are formed at any desired position in the cross-section of the inner core 132.

FIG. 4 is an enlargement of the portion delineated by the curve 4 in FIG. 3. FIGS. 5 and 6 are a cross-sectional view of the embodiment of the deployment catheter 120 shown in FIG. 3 taken along line 5-5 and line 6-6, respectively, of FIG. 4. With reference to FIGS. 4-6, a bifurcated endoluminal graft 50 is illustrated in a compressed configuration within the deployment catheter 120, prior to the advancement of the inner core 132 relative to the other sheath 128. The graft 50 can comprise a distal aortic trunk or main branch portion 52, a proximal ipsilateral branch portion 54, and a proximal contralateral iliac portion 56. In the illustrated embodiment, the aortic main branch portion 52 of the graft 50 can be constrained within a main branch sheath 186. While the embodiment of main branch sheath 186 is shown with reference to compressing a main branch graft portion 52, it is envisioned that the sheath 186 could alternatively be used to compress and deliver other portions of a multi-segmented vascular graft, such as a branch graft portion, the entire multi-segmented graft, or a single-segment, straight vascular graft. Further, in the illustrated embodiment, the ipsilateral branch portion 54 can be constrained with a tubular ipsilateral branch sheath 188 (also referred to herein as the first branch sheath), and the contralateral branch portion 56 (also referred to herein as the second branch sheath) can be constrained within a generally tubular contralateral branch sheath 190. In the illustrated embodiment, the ipsilateral branch sheath 188 and the contralateral branch sheath 190 can be open-ended tubular sheaths.

The ipsilateral branch sheath 188 can constrain substantially the entire length of the ipsilateral branch portion 54 of the bifurcated graft 50. Similarly, in the illustrated embodiment, the contralateral branch sheath 190 can constrain substantially the entire length of the contralateral branch portion 56 of the bifurcated graft 50. However, in some embodiments, the ipsilateral branch sheath 188 and/or the contralateral branch sheath 190 may constrain substantially more or less than the entire length of the ipsilateral branch portion 54 or the contralateral branch portion 56, respectively, of the bifurcated graft 50.

With reference to FIG. 5, the main branch sheath 186 can be sized and configured to circumferentially surround the main branch portion 52 of the bifurcated graft 50. However, in some embodiments, the main branch sheath 186 can be configured to only partially surround the main branch portion 52 of the bifurcated graft 50. The main branch sheath 186 may extend to the distal end of the contralateral branch portion 56 of the graft 50. In some embodiments, the main branch sheath 186 can be configured so as to define a notch 192 along the portion of the length of the main branch sheath 186 that covers the contralateral branch portion 56. In some embodiments, the notch 192 can be a slit along a portion of the length of the main branch sheath 186. In some embodiments, as in the illustrated embodiment, the notch 192 can remove a portion of the main branch sheath 186 along a portion of the length of the main branch sheath 186 that can be less than or equal to approximately half of the perimeter of the main branch sheath 186. In some embodiments, the main branch sheath 186 can be skived to remove a suitable amount of the material comprising the main branch sheath 186 to allow the ipsilateral or contralateral branch portion 54, 56 of the graft 50 to deploy upon retraction of the outer sheath 128. Thus, in some embodiments, the main branch sheath 186 may not constrain the ipsilateral or contralateral branch portion 54, 56 of the bifurcated endoluminal graft 50.

In some embodiments, as illustrated in FIG. 4, a torsion tab 196 can be integrally formed with the central tube 170, or secured thereto such as by thermal bonding, adhesive bonding, and/or any of a variety of other securing techniques known in the art. As is illustrated, the main branch portion 52 of the bifurcated endoluminal graft 50 can be constrained by the main branch sheath 186 around the torsion tab 196. In the illustrated embodiment, the torsion tab 196 can engage with the endoskeleton or, with reference to FIG. 1B, the wire support cage 60 of the bifurcated graft 50 and ensures that the bifurcated graft 50 substantially rotates with the inner core 132 of the deployment catheter 120. In other words, the torsion tab 196 can prevent the central tube 170 from rotating relative to the bifurcated graft 50. This can enhance the ability of the medical practitioner or user to rotate and, hence, maneuver, the graft 50 and the ipsilateral and/or contralateral branch portions 54, 56 within the patient's aorta by rotating the proximal end of the deployment catheter 120, in particular, by rotating the proximal end of the inner core 132 or the “Y” connector 169. As such, the torsion tab 196 can cause the bifurcated endoluminal graft 50 to rotate substantially in unison with the central tube 170.

As described in greater detail below, a locking assembly 300 can couple with the central tube 170. The locking assembly 300 may be integrally formed with the central tube 170, or secured thereto such as by thermal bonding, adhesive bonding, and/or any of a variety of other securing techniques known in the art. The locking assembly 300 can engage a locking portion 194b (shown in FIG. 17A) of a contralateral guidewire 194. The locking portion 194b is also referred to herein as a distal end 194b or as a stiff region. The contralateral guidewire 194 can extend distally from the locking assembly 300 and cannulate the guidewire sheath 216. The contralateral guidewire 194 can then bend proximally back and extend through the main branch portion 52 of the graft 50 and into the contralateral branch portion 56 of the graft 50. The contralateral guidewire 194 and the contralateral guidewire sheath 216 can extend proximally from the contralateral branch portion 56 of the graft 50 and bend back distally, running distally along a gap formed between an inner surface of the outer sheath 128 and an outer surface of the main branch sheath 186. The contralateral guidewire 194 and contralateral guidewire sheath 216 can then exit the delivery catheter 120 through a gap formed between a proximal face of the distal tip 174 and a distal face of the outer sheath 128. The distal tip 174 may include a groove (not shown) that accommodates the contralateral wire 194 as the contralateral wire 194 passes through the junction between the distal tip 174 and the outer sheath 128.

The contralateral branch sheath 190 can be deployed using the contralateral guidewire sheath 216. The ipsilateral branch sheath 188 can be connected to the inner core 132 or the interface member 168 and adapted to be axially proximally withdrawn from the ipsilateral branch portion 182 of the graft 178, thereby permitting the ipsilateral branch portion 182 to expand to its implanted configuration. The main branch sheath 186 can retracted with the contralateral branch sheath 190 or with the ipsilateral branch sheath 188.

Method of Use

With reference to the embodiments of the deployment catheter 120 described above, an exemplary procedure or method of using the deployment catheter 120 to treat a patient's abdominal aortic aneurysm using the embodiments of the bifurcated endoluminal graft 50 disclosed above will now be described. However, the methods and devices of the present disclosure are not to be taken as limited to this particular illustrative example. The present methods and systems can be used in any medical procedure where one desires to reversibly couple catheters, sheaths, guidewires, or similar devices.

In the illustrated embodiment the main branch sheath 186 and the ipsilateral branch sheath 188 are introduced into the patient through the ipsilateral access site and removed from the patient through the ipsilateral access site, while the contralateral branch sheath 190 is introduced through the ipsilateral access site and removed through the contralateral access site.

FIG. 7 is a schematic representation of an embodiment of the deployment catheter 120 with the contralateral guidewire sheath 216 positioned across the bifurcation and within the contralateral iliac artery 38. The hollow contralateral guidewire sheath 216 can be introduced into the ipsilateral iliac artery 37 through an ipsilateral access site in the femoral artery, advanced superiorly towards the aorta 30, and using cross-over techniques known to those skilled in the arts, subsequently advanced inferiorly down the contralateral iliac artery 38 and out a contralateral access site in the contralateral femoral artery. The leading portion 216b of the contralateral guidewire sheath 216 can be externalized by passing the leading portion 216b of the contralateral guidewire sheath 216 through the contralateral access site. As discussed below, the guidewire sheath 216 can be secured to the contralateral branch sheath 190. The contralateral branch portion 56 of the bifurcated graft 50 can be deployed by withdrawing the contralateral guidewire sheath 216 and thereby removing the contralateral branch sheath 190 from the contralateral branch portion 56 of the graft 50. The contralateral branch sheath 190 can be removed through the contralateral access site by pulling on the contralateral guidewire sheath 216.

FIG. 8 is a schematic representation, as in FIG. 7, with the deployment catheter 120 positioned in the aorta 30. Referring to FIG. 8, after the contralateral guidewire sheath 216 the has been positioned across the bifurcation 228 in the aorta 30, the deployment catheter 120 can then be advanced over a second guidewire 226 (also referred to as the main guidewire), such as but not limited to a standard 0.035 in. guidewire, from the ipsilateral access site into the aorta 30 using techniques known to those skilled in the arts. Traction can be applied to the hollow contralateral guidewire sheath 216 from the contralateral access site to take up the slack in the contralateral guidewire sheath 216 as the deployment catheter 120 is advanced into the aorta 30.

FIG. 9 is a schematic representation with the ipsilateral and contralateral branch portions 54, 56 of the graft 50 compressed within the ipsilateral and contralateral branch sheaths 188, 190 (respectively) and positioned substantially fully within the respective ipsilateral and contralateral iliac arteries. As shown in FIG. 9, the bifurcated graft 50 can be configured so as to abut against the bifurcation of the aorta 228 or be positioned in the vicinity of the bifurcation of the aorta 228 by retracting the deployment catheter 120 and, if desired, the contralateral guidewire sheath 216 until the bifurcated graft 50 abuts or is in the vicinity of bifurcation of the aorta 228. The contralateral guidewire 194 can be manipulated so as to seat the graft 50 onto the bifurcation 228 of the aorta 30.

FIG. 10 is a schematic representation, as in FIG. 9, with a proximal portion of the main branch portion 52 of the graft 50 or at least partially deployed within the aorta 30. The proximal portion of the main branch portion 52 of the graft 50 can be partially deployed within the aorta 30 as illustrated by proximally retracting the sheath release wire 166, as described above, while holding the inner core 132 of the deployment catheter (see FIG. 3) in a fixed position relative to the aorta 30 so as to prevent exerting undue force on the bifurcation 228 of the aorta 30 or other portions of the anatomy. Deploying the graft 50 in a bottom up sequence, as illustrated herein, may help mitigate the “wind socking” effect that can cause proximal migration of the graft 50. Additionally, deploying the graft 50 and a bottom up sequence may allow for either axially or rotationally repositioning of a partially deployed graft 50 without causing significant or any damage to the arterial wall. In some embodiments, this may partly be due to the fact that the deployed middle portion of the graft 50 may move against the arterial wall more easily than a deployed end portion of the graft 50. The main branch sheath 186 can be attached to the sheath release wire 166 and withdrawn from the patient through the ipsilateral access site.

FIG. 11 is a schematic representation, as in FIG. 10, following the further proximal retraction of the contralateral guidewire sheath 216 and, consequently, the contralateral branch sheath 190, through the contralateral iliac artery 38. As illustrated therein, the contralateral branch sheath 190 has been retracted so as to completely deploy the contralateral branch portion 56 of the bifurcated graft 50. The contralateral guidewire 194 may remain coupled to the locking assembly 300 as the contralateral guidewire sheath 216 is withdrawn through the contralateral access site.

FIG. 12A is a schematic representation, as in FIG. 11, following the proximal retraction of the ipsilateral branch sheath 188 and deployment of the ipsilateral branch portion 54 of the graft 50. The ipsilateral branch portion 54 of the graft 50 may be deployed by proximally retracting the inner core 132 which, as described above, can be directly or indirectly rigidly attached to the ipsilateral branch sheath 188 (see FIG. 3). Because the ipsilateral branch sheath 188 can be an open-ended tubular sheath, the ipsilateral branch portion 54 of the graft 50 can be deployed in a top down sequence.

However, the ipsilateral branch sheath 188 (and the contralateral branch sheath 190) can be configured to accommodate any other desired or suitable sequence. In some embodiments, the ipsilateral branch portion 54 of the bifurcated graft 50 may be deployed before deployment of the contralateral branch portion 56 of the graft 50. Additionally, although the figures illustrate the main branch portion 52 of the graft 50 being deployed with the contralateral branch portion 56, in other embodiments, the main branch portion 52 of the graft 50 may be deployed with the ipsilateral branch portion 54. Also, although the figures illustrate the ipsilateral branch portion 54 being deployed before the contralateral branch portion 56, in other methods, the contralateral branch portion 56 may be deployed before the ipsilateral branch portion 54 of the graft 50.

In the illustrated embodiment depicted in FIG. 12A, the contralateral guidewire 194 remains coupled to the locking assembly 300 after deployment of the bifurcated graft 50. The locking assembly 300 retains the distal end 194b (shown in FIG. 17A) of the contralateral guidewire 194 to prevent unintended movement of the distal end of the contralateral guidewire 194. The locking assembly 300 can be configured to allow the medical technician to actuate the locking assembly 300, thereby triggering the locking assembly 300 to release the distal end of the contralateral guidewire 194.

Referring to FIGS. 12B-D, release of the contralateral guidewire 194 from the locking assembly 300 may be accomplished by advancing a release member 311 (e.g., pigtail catheter) along the contralateral guidewire 194. The release member 311 can then directly or indirectly apply a vertical force to the contralateral guidewire 194, thereby causing the locking assembly 300 to release the distal end 194b of the contralateral guidewire 194. The release member 311 can then be withdrawn through the contralateral access site. The contralateral guidewire 194 can be withdrawn before, after, or at the same time as the withdrawal of the release member 311. Additionally or alternatively, the release member 311 can be configured to release the contralateral guidewire 194 upon the activation of a triggering element that is coupled to the locking device 300, as described below.

Although the illustrated method shows the ipsilateral branch portion 54 of the graft 50 being released before withdrawing the contralateral guidewire 194, in some methods, the contralateral guidewire 194 may be released (e.g., as shown in FIGS. 12B-12D) prior to releasing the ipsilateral branch portion 54 (e.g., as shown in FIG. 12A).

Locking Assembly

FIG. 13A is a schematic representation of a locking assembly 300. The locking assembly 300 may be interfaced with (e.g., removably coupled, permanently secured, or integrally formed with) a first elongate member 303 and a second elongate member 305. The locking assembly 300 may be configured to interface with more than two elongate members. The first elongate member 303 may pass through the locking assembly 300. The locking assembly 300 can interface with an anchor portion 307 of the first elongate member 303. The locking assembly 300 may reversibly couple to a locking portion 309 of the second elongate member 305.

FIG. 13B is a non-limiting example of a locking assembly 300 that can be used with any embodiment of the deployment catheter 120 disclosed herein. In general, the locking assembly 300 presently disclosed can be configured to secure two elongate members to the locking assembly 300. The locking assembly 300 can be adapted to release one of the elongate members from the locking assembly 300 when a user applies a vertical force to the elongate member being released. The locking assembly 300 presently disclosed can be used in medical procedures that employ a junction of two wires from different locations, such as procedures deploying bifurcated stents or multiple stents in thoracic, renal, or cardiac procedures. By way of a non-limiting example, the locking assembly 300 can be used to join a contralateral guidewire to an ipsilateral catheter when deploying a bifurcated stent in order to treat an abdominal aortic aneurysm. Certain aspects of the locking assembly 300 will now be described by presenting a variety of non-limiting exemplary embodiments of the locking assembly 300.

Referring to FIG. 13B, the locking assembly 300 can include a housing 301 having a distal face 302 and a proximal face 304. As shown in FIG. 13B, the proximal and distal faces 304, 302 may be substantially perpendicular to the longitudinal axis 306. However, in other configurations the proximal and distal faces 304, 302 may not be substantially perpendicular to the longitudinal axis 306 and/or parallel with each other. The locking assembly 300 can include an anchoring surface 308 that defines a first lumen 310. The first lumen 310 may communicate between the distal face 302 and the proximal face 304 of the housing 301. As shown in FIG. 13B, the first lumen 310 may be concentric to the longitudinal axis 306 of the locking assembly 300. However in other configurations, the first lumen 310 may be off-center of the longitudinal axis 306 of the locking assembly 300.

The elongate member can pass through the first lumen 310 of the locking assembly 300, e.g., the central tube 170 of the delivery catheter 120 can pass through the first lumen 310. The locking assembly 300 can be integral with the central tube 170 or bonded to the central tube 170 so that there is no relative movement between the locking assembly 300 and the central tube 170 as the central tube 170 is moved in a distal or proximal direction. The central tube 170 can be secured to the anchoring surface 308 such as by thermal bonding, adhesive bonding, crimping, or any of a variety of other securing techniques known in the art.

Additionally or alternatively, the locking assembly 300 can include a second lumen 312. The second lumen 312 is a passage between the distal face 302 and the proximal face 304 of the housing 301. However, in other configurations, the second lumen 312 may communicate only with the distal face 302, and not with the proximal face 304, of the housing 301. The second lumen 312 can be configured to retain a second elongate member (e.g., the contralateral guidewire 194) to the locking assembly 300. The contralateral guidewire 194 can be released from the second lumen 312 upon activation of the locking assembly 300 by a user.

The locking assembly 300 can include a first recess 314 that extends from a lateral wall 316 of the housing 301 toward the longitudinal axis 306 of the locking assembly 300. The second lumen 312 can communicate with the first recess 314. Additionally or alternatively, the first lumen 310 can communicate with the first recess 314. The locking assembly 300 can include a second recess 320 that extends from the lateral wall 316 of the housing 301 toward the longitudinal axis 306 of the locking assembly 300. The locking assembly 300 can include a divider 322 that is interposed between the first recess 314 and the second recess 320. The locking assembly 300 can include a through-hole 324 that extends through the divider 322 and communicates between the first and second recesses 314, 320 to form a recessed portion.

A proximal portion 326 of the locking assembly 300 can be tapered. The proximal portion 326 can be tapered so that the transverse cross-sectional area of the proximal portion 326 decreases along the proximal direction. The proximal portion 326 can be tapered to allow the proximal portion 326 to be withdrawn out of the graft 50 and back into the outer sheath 128 without having the locking assembly 300 getting caught on the graft 50 or the outer sheath 128 or any other intervening structure. The locking assembly 300 can have a taper angle defined as the angle between the longitudinal axis 306 of the locking assembly 300 and the lateral wall of the proximal portion of the locking assembly 300. The taper angle can be between about 15 and 60 degrees, between about 20 and 45 degrees, and between about 25 and 35 degrees. The taper angle can be 30 degrees with a tolerance of 1 degree.

A distal portion 330 of the locking assembly 300 can include a protrusion 332, extending radially outward from housing 301. The protrusion 332 may circumferentially surround the entire distal portion 330 of the locking assembly 300, or may surround only a portion of the distal portion 330 of the locking assembly 300. The protrusion 332 may extend from only a portion of the distal portion 330. The second lumen 312 can be interposed between the protrusion 332 and the first lumen 310. The protrusion 332 can be configured to provide strain relief to an elongate member that extends distally from the second lumen 312 and then bends back in the proximal direction. The protrusion 332 can have a radius of curvature between about 0.005 and 0.1 inches, between about 0.01 and 0.05 inches, and between about 0.015 and 0.025 inches. The protrusion 332 can have a radius of curvature of 0.02 inches with a tolerance of 0.01 inches.

The locking assembly 300 can have a length dimension that defines the distance between the proximal and distal faces 304, 302. The length dimension can be between about 0.1 and 1.0 inches, between about 0.2 and 0.5 inches, and between about 0.3 and 0.4 inches. The length dimension can be 0.375 inches with a tolerance of 0.010 inches. The locking assembly 300 can have a width dimension perpendicular to the length dimension. The width dimension can be between about 0.05 and 0.5 inches, between about 0.1 and 0.3 inches, and between about 0.15 and 0.2 inches. The width dimension can be 0.187 inches with a tolerance of 0.002 inches. The locking assembly 300 can have a first aspect ratio defined as the length dimension divided by the width dimension. The first aspect ratio can be between about 0.5 and 5, between about 1 and 3, and between about 1.75 and 2.25. The first aspect ratio can be 2.0.

The first lumen 310 of the locking assembly 300 can have a diameter of between about 0.01 and 0.2 inches, between about 0.02 and 0.1 inches, and between about 0.04 and 0.06 inches. The first lumen 310 can have a diameter of 0.055 inches with a tolerance of 0.002 inches. The second lumen 312 of the locking assembly 300 can have a diameter of between about 0.01 and 0.1 inches, between about 0.02 and 0.05 inches, and between about 0.03 and 0.04 inches. The second lumen 312 can have a diameter of 0.033 inches with a tolerance of 0.002 inches. The locking assembly 300 can have a second aspect ratio defined as the diameter of the first lumen 310 divided by the diameter of the second lumen 312. The second aspect ratio of the locking assembly 300 can be between about 1 and 3, between about 1.5 and 2. The second aspect ratio of the locking assembly 300 can be 1.667. The center points of the first and second lumens can be separated from one another by a spacing dimension. The spacing dimension can be between about 0.04 and 0.07 inches, and between 0.05 and 0.06 inches. The spacing dimension can be 0.053 inches with a tolerance of 0.002 inches.

The locking assembly 300 can include an elastomeric member 334. The elastomeric member 334 may occupy at least a portion of the first recess 314. The elastomeric member 334 can have an outer surface 336 that is flush with at least a portion of the lateral wall of the locking assembly 300. The first recess 314 can be configured to retain the elastomeric member 334 within the locking assembly 300. Additionally or alternatively, the elastomeric member 334 may occupy at least a portion of the second recess 320. The second recess 320 can be configured to retain the elastomeric member 334 within the locking assembly 300. The elastomeric member 334 can be configured to span the divider 322. The elastomeric member 334 can have a first portion that resides in the first recess 314 while a second portion of the elastomeric member 334 resides in the second recess 320, the first and second portions of the elastomeric member 334 being connected by a segment of the elastomeric member 334 that extends through the through-hole 324.

The elastomeric member 334 can be configured to enhance the ability of the second lumen 312 to retain the contralateral guidewire 194 of the delivery catheter 120. For example, the elastomeric member 334 can be configured to intrude into at least a portion of the second lumen 312. The locking assembly 300 can be configured so that at least a portion of the elastomeric member 334 can interface with an elongate member inserted into the second lumen 312. The elastomeric member 334 may form a friction fit with an elongate member inserted into the second lumen 312, helping to retain the elongate member in the second lumen 312. Different non-limiting exemplary embodiments of the elastomeric member 334 are discussed below.

FIG. 14 shows an isometric view of one exemplary embodiment of the elastomeric member 334. The elastomeric member 334 can include a first portion 340 that is configured to be retained within the first recess 314 of the locking assembly 300. Additionally or alternatively, the elastomeric member 334 may include a second portion 342 that is configured to be retained within the second recess 320 of the locking assembly 300. The first portion 340 can be connected to the second portion 342 by at least one segment 344. In the non-limiting exemplary example depicted in FIG. 14 the elastomeric member 334 can include a first portion 340 joined to a second portion 342 by two segments 344, the segments 344 being cylindrical in shape. The elastomeric member 344 can include a segment 344 having a shape other than cylindrical. The second portion 342 and the segment 344 can be configured to enhance retention of the elastomeric member 334 within the housing 301 of the locking assembly 300. The second portion 342 can provide a mechanical lock between the elastomeric member 334 and the housing 301 of the locking assembly 300, thereby increasing the strength of the attachment between the elastomeric member 334 and the housing 301.

The elastomeric member 334 can include a retention portion 346 configured to retain a second elongate member 305 that is inserted into the second lumen 312 of the locking assembly 300. The retention portion 346 can define an opening 348 (e.g., through-hole, lumen, or otherwise) that extends at least partially through the elastomeric member 334, e.g., between a distal face 350 and a proximal face 352 of the elastomeric member 334 or only in communication with the distal face 350 of the elastomeric member 334. The opening 348 can be concentric with the second lumen 312 of the locking assembly 300 when the elastomeric member 334 is seated within the first recess 314 of the locking assembly 300.

An end portion of the opening 348 has a diameter 356 that can be larger than an intermediate diameter 360 of an intermediate portion 362 of the retention portion 346. The end portion 354 of the retention portion 346 can be configured to guide an elongate member into the intermediate portion 356 of the retention portion 346. The end portion 354 of the retention portion 346 can include a canted wall that funnels an inserted elongate member into the intermediate portion 356 of the retention portion 346.

The elastomeric member 334 can include a passageway defined by a curved surface 364 that aligns with the first lumen 310 of the locking assembly 300. The curved surface 364 of the elastomeric member 334 can interface with (e.g., by bonding) the housing 301 of the locking assembly 300. The housing 301 of the locking assembly can interface with (e.g., by welding) to the elongate member that passes through the first lumen of the locking assembly 300.

The elastomeric member 334 can include a curved portion 366. The curved portion 366 can be configured to enhance the bonding between the elastomeric member 334 and the housing 301 of the locking assembly 300. FIG. 14A is a top view of the elastomeric member 334 depicted in FIG. 14. FIG. 14B is an offset rear view of the elastomeric member 334 depicted in FIG. 14, showing the curved portion 366 in more detail. FIG. 14C is a front cross-sectional view of the elastomeric member 334 depicted in FIG. 14. FIG. 14D is an offset front view of the elastomeric member 334 depicted in FIG. 14.

FIG. 15 depicts a cross-sectional view of an exemplary embodiment of the locking assembly 300. The elastomeric element 334 can include a retention portion 346 that at least partially aligns with the second lumen 312. The retention portion 346 can include an opening 348 having a width 370. The width 370 of the passageway of the retention portion 346 can be smaller than the width 372 of the second lumen 312, thereby causing at least a portion of the retention portion 346 to intrude upon the second lumen 312. The retention portion 346 can define an opening 348 that partially aligns with the second lumen 312. For example, the retention portion 346 may intrude upon the second lumen 312 from only one side. In some configurations, the retention portion 346 can be cup-shaped, with the mouth of the cup-shaped retention portion 346 facing the distal surface 302 of the locking assembly 300.

As discussed, in some embodiments, the retention portion 346 can include an opening 348 formed within the elastomeric member 334. The elastomeric member 334 can be made of an elastic material such as silicone. The opening 348 of the retention portion 346 can stretch and/or compress to accommodate an elongate member inserted into the retention portion 346. The retention portion 346 can be configured to form a friction fit with an elongate member inserted into the opening 348 of the retention portion 346. The friction fit between the retention portion 346 and the elongate member can resist distal movement of the elongate member relative to the retention portion 346 until the elongate member is subjected to sufficient tension in the distal direction.

FIG. 16 depicts a cross-sectional view of a non-limiting alternative embodiment of the locking assembly 300′ that includes the housing 301′ but not include an elastomeric member 334′. The housing 301′ can be substantially similar to that described above except without a recessed portion configured to receive the elastomeric member. In this embodiment, the locking assembly 300′ can include a retention portion 346′ which can include the second lumen 312′. The second lumen 312′ can have a uniform cross-sectional area or a non-uniform cross-sectional area (e.g., a constriction of the second lumen 312′). A distal portion 374′ of the second lumen 312′ can have a width 376′ that is greater than a width 380′ of an intermediate portion 382′ of the second lumen 312′. The second lumen 312′ may include a proximal portion 384′ that is proximal of the intermediate portion 382′ of the second lumen 312′. The proximal portion 384′ can have a width 386′ that is greater than the width 380′ of the intermediate portion 382′. The operation of the retention portion 346′ is discussed below.

FIGS. 17A and 17B schematically illustrate a method of releasing the guidewire from the locking assembly 300 that can be used in connection with both the locking assemblies with and without the elastomeric member (shown in FIGS. 15 and 16). Although these figures illustrate the second lumen 312″ having a generally uniform diameter, the diameter may vary as shown in FIG. 16. FIG. 17A depicts a non-limiting exemplary embodiment of the locking assembly 300″ with a distal portion 194b (also called the locking portion) of the contralateral guidewire 194 inserted into the second lumen 312″ of the locking assembly 300″. When the contralateral guidewire 194 is inserted into the locking assembly 300″, general advancement and retraction of the contralateral guidewire 194 without the appropriate vertical force and/or actuation will not release the contralateral guidewire 194 from the locking assembly 300″.

The contralateral guidewire 194 can include multiple regions, with each region having a different stiffness. For example, the stiffness of the locking portion 194b of the contralateral guidewire 194 can be selected to be higher than the stiffness of a proximal portion 194a (also called the floppy region) of the contralateral guidewire 194. 194194194194 By designing the floppy region 194a to have a low stiffness, the a proximal portion 194a of the contralateral guidewire 194 will be sufficiently flexible to avoid causing damage to surrounding tissue. The tensile strength of the floppy region 194a can be greater than about 1 lbf, greater than about 2 lbf, greater than about 6 lbf, and greater than about 8 lbf.

The locking portion 194b of the contralateral guidewire 194 can extend from the floppy region 194a of the contralateral guidewire 194 at an interface 406″. The length 410″ of the locking portion 194b can be selected from different lengths. In some embodiments, the length of the locking portion 194b″ can be between about 0.3 and 0.8 cm. Additionally or alternatively, the insertion depth of the locking portion 194b into the second lumen 312″ can be adjusted. The contralateral guidewire 194 and the locking assembly 300″ may be tailored so that the interface 406″ can be located distal, proximal, or co-planar to the distal face 302″ of the locking assembly 300″.

During use, a user may pull on the contralateral guidewire 194, creating a tension 412″ in the contralateral guidewire 194, thereby causing the contralateral guidewire 194 to bend in the proximal direction, as illustrated in FIG. 17A. Additionally or alternatively, a user may push on the contralateral guidewire 194, causing a compressive force 414″ that buckles the contralateral guidewire 194 in the distal direction, thereby pushing the locking portion 194b into the retention portion 346″. The locking assembly 300″ can include a protrusion 332″ that provides strain relief to the contralateral guidewire 194 when the contralateral wire 194 bends back in the proximal direction. The position of the interface 406″ relative to the distal face 302″ of the locking assembly 300″ can be selected so that as the tension 412″ pulls on the interface 406″, the locking portion 194b of the contralateral guidewire 194 is retained against a lateral surface 416″ of the retention portion 346″, thereby preventing the contralateral guidewire 194 from decoupling from the locking assembly 300″. The clearance between the locking portion 194b and the lateral surface 416″ can also be selected to further define the tension 412″ required to decouple the contralateral guidewire 194 from the locking assembly 300″. The locking assembly 300″ can be configured to release the locking portion 194b of the contralateral guidewire 194 when a force is applied to an intermediate portion of the contralateral guidewire 194 at an angle of less than or equal to about 60 degrees from the locking portion 194b of the contralateral guidewire 194 and/or at least about 45 degrees from the locking portion 194b″ of the contralateral guidewire 194″.

FIG. 17B shows an illustrative embodiment of a locking assembly 300″ that is configured to release the contralateral guidewire 194 upon a release member 311 (e.g., pigtail catheter) contacting with the locking assembly 300″ and applying a vertical force to draw the locking portion 194b of the contralateral guidewire 194 out of the retention portion 346″. In the non-limiting exemplary locking assembly 300″ depicted in FIG. 17B, the release member 311 can be a release sheath that is configured to be disposed over the contralateral guidewire 194. The release member 311 may completely circumferentially surround the contralateral guidewire 194, or the release member 311 may only partially circumferentially surround the contralateral guidewire 194. The release member 311 may be composed of a plurality of segments. The segments may be identical to one another or different from one another. Some, all, or no segments may completely circumferentially surround the contralateral guidewire 194 while some, all, or no other segments only partially surround the contralateral guidewire 194. The segments may be separated from one another by one or more hinge points. The hinge points may be configured to allow the segments to bend, flex, or pivot relative to one another.

The release member 311 can be introduced at the contralateral access site by passing the distal end of the release member 311 over the proximal end of the contralateral guidewire 194. The release sheath 420″ can be advanced over the contralateral guidewire 194 until the distal face of the release member 311 engages the distal face 302″ of the locking assembly 300″. The outer diameter of the distal face of the release member 311 can be selected so that the distal face abuts against the distal face 302″ of the locking assembly. As a user applies a compressive force 414″ to the release member 311 and contralateral guidewire 194, the release member 311 buckles in the distal direction. As the release member 311 buckles (loops, forms a U-shape, or otherwise bends) in the distal direction, the portion of the contralateral guidewire 194 that distally extends from the retention member 346″ of the locking assembly 300″ is aligned to be substantially perpendicular to the distal face 302″ of the locking assembly 300″. A user may now apply tension 412″ to the contralateral guidewire 194. Once a distally extending portion of the contralateral guidewire 194 is longitudinally aligned with the retention member 346″, the 194 the contralateral guidewire 194 is released from the retention member 346″. The locking assembly 300″ can be configured to retain the contralateral guidewire 194 until a vertical force of at least 0.1 lbf (or at least about 0.5 lbf, at least about 1.0 lbf, or otherwise) is applied to the contralateral guidewire 194.

The reversible coupling of the contralateral guidewire 194 to the locking assembly 300 can be accomplished by alternative embodiments that are within the scope of the present disclosure. For example, the locking assembly 300″ depicted in FIGS. 17A-B can include an elastomeric member 334, as discussed above. Additionally or alternatively, the locking assembly 300 can include any of the features depicted in the alternative embodiments depicted in FIGS. 18A-R.

FIG. 18A depicts an embodiment where the locking portion 194b of the contralateral guidewire 194 is retained by wrapping the locking portion 194b of the contralateral guidewire 194 over the main branch portion 52 of the graft 50. The locking portion 194b can be secured to the outer surface of the main branch portion 52 by a sheath (not shown) that is deployed by a suture (not shown) as described above for the deployment of the main branch portion 52 of the graft 50. The locking portion 194b may be larger in diameter, longer, and/or more rigid than remaining portions of the contralateral guidewire 194. The sheath that secures the locking portion 194b can be the main branch sheath 186 or a sheath different from the main branch sheath 186.

FIG. 18B depicts an embodiment of the locking assembly 300 that can have a track 428 configured to retain the locking portion 194b of the contralateral guidewire 194. The locking portion 194b may be larger and/or more rigid than a remaining portion of the contralateral guidewire 194 to help retain the locking portion 194b within the track 428. The track 428 may be an open faced channel having a variable width so that when tension is applied to the contralateral guidewire 194 the locking portion 194b is drawn up into a necked region of the track 428, thereby constraining the locking portion 194b from escaping the track 428. Additionally or alternatively, a region of the track 428 may be an open faced channel having an enlarged region where the width of the track 428 is larger than the width of the locking portion 194b. A user may free the contralateral guidewire 194 from the locking assembly 300 by advancing the locking portion 194b of the contralateral guidewire 194 until the locking portion 194b is aligned with the enlarged region of the track 428, thereby allowing the locking portion 194b to escape the track 428.

FIG. 18C depicts an embodiment of the locking assembly 300 that has a retaining wire 430. The retaining wire 430 can be configured to hold the contralateral guidewire 194 against the distal face 302 of the locking assembly 300, thereby keeping the locking portion 194b within the retention portion 346 of the locking assembly 300. The retention portion 346 can be a groove on the side of the housing 301 of the locking assembly 300. The retention portion 346 may be a pocket 432 that is surrounded by the housing 301. The width of the groove or pocket 432 may vary as described above. The retaining wire 430 can be configured to be withdrawn from the locking assembly 300, thereby allowing the locking portion 194b to potentially release from the pocket 432.

FIG. 18D depicts an embodiment of the locking assembly 300 that has a clamp 434. The top portion 436 of the clamp 434 may be pulled against the bottom portion 438 of the clamp 434 by a spring 440 that is connected to the top portion 436 by a tension element 442. The contralateral guidewire 194 may be coupled to the locking assembly 300 by virtue of being compressed between the top and bottom portions 436, 438 of the clamp 434. A user may activate a trigger 444 to compress the spring 440 reducing the tension element, thereby reducing the compressive force between the top and bottom portions 436, 438 of the clamp 434 and allowing the contralateral guidewire 194 to decouple from the locking assembly 300. In other embodiments, the tension in the spring 440 may be released by moving the trigger 444 or by releasing the tension on the spring 440.

FIG. 18E depicts an embodiment of the locking assembly 300 having a duckbill valve 446. The duckbill valve 446 can be configured to retain a locking portion 194b at the distal end of the contralateral guidewire 194. The locking portion 194b may be larger and/or more rigid than a remaining portion of the contralateral guidewire 194. A user may decouple the contralateral guidewire 194 from the locking assembly 300 by advancing the contralateral guidewire 194 to allow the locking portion 194b to escape the duckbill valve 446.

FIG. 18F depicts an embodiment of the locking assembly 300 configured to retain a bead 448 attached to the contralateral guidewire 194. The bead 448 can interface with (e.g., by bonding) the contralateral guidewire 194. As shown in FIG. 18F, the bead 448 can sit within a channel 445 that has a narrow proximal portion and a wider distal portion. The narrow proximal portion of the channel 445 can be configured to prevent the bead 448 from being pulled proximally through the channel. The wider portion of the channel can have an overhang 447 that can be configured to prevent the bead 448 from leaving the channel 445 unless the bead 448 is advance sufficiently far distally to clear the overhang 447.

FIG. 18G depicts an embodiment of the locking assembly 300 having a plastic retention member 390 (e.g., soft wing) that can be located within the main branch portion 52 of the graft 50. The plastic retention member 390 can interface (e.g., by friction, press fit, molded, adhered, thermally bonded, mechanically locked, otherwise secured) with the central tube 170. The contralateral guidewire 194 can extend distally through the graft 50, pass over or through a housing member and bend proximally back into the graft 50 to terminate at the plastic retention member 390. The locking portion 194b of the contralateral guidewire 194 can be configured to be retained by the plastic retention member 390 as described above in FIG. 18B.

FIG. 18H depicts an embodiment of the locking assembly 300 having a wrapper 450. The wrapper 450 can enclose at least a portion of the housing 301 of the locking assembly 300. The wrapper 450 can be configured to restrain the locking portion 194b of the contralateral guidewire 194 within a channel 452 formed in the side of the housing 301. The wrapper 450 can be removed by a control suture 454, thereby allowing the locking portion 194b to escape the channel 452.

FIG. 18I depicts an embodiment of the locking assembly 300 having a rigid sheath 456. The rigid sheath 456 can be configured to press the contralateral guidewire 194 against an abutment 458, thereby locking the contralateral guidewire 194 to the locking assembly 300. The contralateral guidewire 194 may be decoupled from the locking assembly 300 by proximally withdrawing the rigid sheath 456 or distally advancing the abutment 458. A control rod 460 attached to the abutment 458 can allow a user to distally advance the abutment 458. The locking portion 194b may be larger and/or more rigid than a remaining portion of the contralateral guidewire 194 locking portion

FIG. 18J depicts an embodiment of the locking assembly 300 having a curved groove 462. The curved groove 462 may be S-shaped, U-shaped, sinusoidal, zig-zag-shaped or combinations thereof. The curved groove 462 may be formed in the outer surface of the housing 301 of the locking assembly 300 described above. The contralateral guidewire 194 may include a locking portion 194b that has a width or length that prevents the locking portion 194b from being pulled through the curved groove 462. The locking assembly 300 can be configured so that when the contralateral guidewire 194 is advanced distally the locking portion 194b of the contralateral guidewire 194 may peel out of the housing 301, thereby freeing the contralateral guidewire 194 from the locking assembly. Additionally or alternatively, the locking assembly 300 may be configured so that a release member 311 is advanced over the contralateral guidewire 194 to assist in freeing the contralateral guidewire 194 from the locking assembly 300.

FIG. 18K depicts an embodiment of the locking assembly 300 having an extended portion 464 of the contralateral branch sheath 190. The extended portion 464 may wrap around a portion of the locking assembly 300, thereby retaining the locking portion 194b of the contralateral guidewire 194 within a pocket 432 of the locking assembly 300. The extended portion 464 may be held closed by a suture. The suture can be coupled to the contralateral branch sheath 190. The suture can be configured to separate the extended portion 464 from the housing 301 as the contralateral branch sheath 190 is proximally withdrawn, thereby freeing the locking portion 194b of the contralateral guidewire 194 from the locking assembly 300.

FIG. 18L depicts an embodiment of the locking assembly 300 having a contralateral guidewire 194 that extends into the ipsilateral branch portion 54 of graft 50. The ipsilateral limb pinches, compresses, or otherwise provides friction such that the guidewire when inadvertently advanced does not disconnect from the catheter until the ipsilateral branch portion is deployed. The contralateral guidewire 194 may extend through a bead 448. The bead 448 may be configured to be retained within a channel 452 formed in the side of or through the housing 301 of the locking assembly 300 as described above.

FIG. 18M depicts an embodiment of the locking assembly 300 having a folded portion 194c of the contralateral guidewire 194 that is folded over the ipsilateral branch portion 54 of the graft 50. The folded portion 194c may be held against an outer surface of the ipsilateral branch portion 54 by the ipsilateral branch sheath 188. Retraction of the ipsilateral branch sheath 188 may then free the folded portion 194c, thereby allowing the contralateral guidewire 194 to be removed from the locking assembly 300.

FIG. 18N depicts an embodiment of the locking assembly 300 having ipsilateral locking member 468. The ipsilateral locking member 468 can include a channel 452 configured to retain a locking portion 194b or bead 448 that is coupled to the contralateral guidewire 194, as discussed above.

FIG. 18O depicts an embodiment of the locking assembly 300 having a bent channel 470. The bent channel 470 can be configured so that the locking portion 194b of the contralateral guidewire 194 is unable to navigate through the bent channel 470. The locking portion 194b of the contralateral guidewire 194 can be decoupled for the locking assembly 300 by advancing the locking portion 194b proximally through the bent channel 470.

FIG. 18P depicts an embodiment of the locking assembly 300 having a ball feature 472 at the locking portion 194b of the contralateral guidewire 194. The ball feature 472 can be configured to function similar to the bead 448 described above for FIG. 18F. The ball feature 472 may be configured to be too large to pass proximally through the channel of the locking assembly 300. The ball feature can be configured so that the locking portion 194b is freed from the locking assembly when the ball feature is advanced distally, thereby allowing the contralateral guidewire 194 to peel out of the channel in the locking assembly 300.

FIG. 18Q depicts an embodiment of the locking assembly 300 having a segmented locking channel 474. The segmented locking channel 474 may include a plurality of segments 476a, b, each having a groove 475 formed into the surface of the segment 476a, b. The segments 476a,b may be joined together by a coupling member 478. The contralateral guidewire 194 may navigate through the segmented locking channel 474. The locking portion 194b of the contralateral guidewire 194 may be retained within a pocket 432 that is formed in one of the segments 476b of the plurality of segments 476a,b.

FIG. 18R depicts an embodiment of the locking assembly 300 having a magnetic component 480. The magnetic component 480 can be disposed within the pocket 432 formed into the housing 301 of the locking assembly 300. The locking portion 194b of the contralateral guidewire 194 may include magnetic material that causes the locking portion 194b to be magnetically attracted to the magnetic member 180, thereby resisting upward forces 412 on the contralateral guidewire 194 from decoupling the locking portion 194b of the contralateral guidewire 194 from the locking assembly 300.

FIG. 19 depicts a non-limiting exemplary embodiment of the contralateral guidewire 194. The contralateral guidewire 194 can be configured to include multiple regions that are joined together. The contralateral guidewire 194 can have a first end 194f and a second end 194g. The serial arrangement of the multiple regions of the contralateral guidewire can be varied according to the needs of the user. The serial arrangement of the regions of the contralateral guidewire 194 shown in FIG. 19 is illustrative only and not to be taken as limiting. The contralateral guidewire 194 can include a wire core, shrink tube made of suitable material (e.g., PTFE), adhesive, alloys containing platinum, and combinations thereof. The platinum alloys can contain 90% platinum and 10% irradium, or 92% platinum and 8% tungsten.

The contralateral guidewire 194 may include a distal coil made of wire containing platinum, e.g., at least about 90% platinum, at least about 92% platinum, at least about 95% platinum, or at least about 99% platinum. In some embodiments, the contralateral guidewire 194 can be constructed from about 92% platinum and 8% tungsten. The distal coil may be made of wire having an outer diameter of 0.003 inches. The distal coil may have a pitch of 0.003 inches. The distal coil may have a coil outer diameter of 0.025 inches. The distal coil may have a coil length of 8.0 cm with a tolerance of 0.3 cm.

The contralateral guidewire 194 may include a proximal coil made of wire containing 92% platinum and 8% tungsten. The proximal coil may be made of wire having an outer diameter of 0.003 inches. The proximal coil may have a pitch of 0.003 inches. The proximal coil may have a coil outer diameter of 0.025 inches. The proximal coil may have a coil length of 15.0 cm with a tolerance of 0.3 cm.

A first region 194h (denoted as having a diameter of P in FIG. 19) of the contralateral guidewire 194 can have a diameter of 0.0160 inches with a tolerance 0.0002 inches. The first region 194h can have a length of 0.3 cm with a tolerance of 0.1 cm. A second region 194i (denoted as having a diameter of R in FIG. 19) of the contralateral guidewire 194 can have a smaller diameter than the first region 194h, e.g., less than or equal to one-half the diameter of the first region 194h. For example, the diameter of the second region 194i can be about 0.0080 inches with a tolerance 0.0002 inches. The second region 194i can be longer than the first region 194h. For example, the second region 194i can have a length of 10.4 cm with a tolerance of 0.1 cm. A third region 194j (denoted as having a diameter of V in FIG. 19) of the contralateral guidewire 194 can have a larger diameter than the first and second regions 194h, 194i. For example, the diameter of the third region 194j can be about 0.0174 inches with a tolerance 0.0002 inches. The third region 194j can be longer than the first region 194h and/or shorter than the second region 194i. For example, the third region 194j can have a length of 1.0 cm with a tolerance of 0.1 cm. A fourth region 194k (denoted as having a diameter of K in FIG. 19) of the contralateral guidewire 194 can have a diameter greater than the first, second, and third regions 194h, 194i, 194j. For example, the fourth region 194k can have a diameter of about 0.0300 inches with a tolerance 0.0003 inches. A fifth region 194l (denoted as having a diameter of H in FIG. 19) of the contralateral guidewire 194 can have a diameter that is less than the diameter of the fourth region 194k, but greater than the diameter of the first, second, and third regions 194h, 194i, 194j. For example, the diameter of the fifth region 194l can be about 0.0210 inches with a tolerance 0.0002 inches. The fifth region 194l can be greater than each of the preceding regions 194h, 194i, 194j, 194k. For example, the fifth region 194l can have a length of 40.8 cm with a tolerance of 0.5 cm. A sixth region 194m (denoted as having a diameter of U in FIG. 19) of the contralateral guidewire 194 can have a diameter that is about the same as the diameter of the third region 194j. For example, the diameter of the sixth region 194m can be about 0.0174 inches with a tolerance 0.0002 inches. The sixth region 194m can be shorter than the can have a length of 0.8 cm with a tolerance of 0.1 cm. A seventh region 194n (denoted as having a diameter of B in FIG. 19) of the contralateral guidewire 194 can have a diameter that is about the same as the second region 194i. The diameter of the seventh region 194n may provide the smallest diameter of the contralateral guidewire 194. For example, the seventh region 194n can have a diameter of 0.0080 inches with a tolerance 0.0002 inches. The seventh region can have a length of 5.2 cm with a tolerance of 0.1 cm. An eighth region 194o (denoted as having a diameter of G in FIG. 19) of the contralateral guidewire 194 can have a diameter that is about the same as the diameter of the first region 194h. For example, the eighth region 194o can have a diameter of about 0.0160 inches with a tolerance 0.0002 inches. The eighth region 194o can have a length of 0.5 cm with a tolerance of 0.1 cm. The contralateral guidewire 194 may include transition regions that soften diameter changes in the contralateral guidewire 194. The transition regions may have a tapering angle that is formed between the longitudinal axis of the contralateral guidewire 194 and the outer wall of the transition region. The tapering angle of the transition regions can range between 10 and 60 degrees.

Terminology

While the above description has shown, described, and pointed out novel features as applied to various embodiments, it will be understood that various omissions, substitutions, and changes in the form and details of the device or process illustrated may be made without departing from the spirit of the disclosure. Additionally, the various features and processes described above may be used independently of one another, or may be combined in various ways. All possible combinations and subcombinations are intended to fall within the scope of this disclosure.

As will be recognized, certain embodiments described herein may be embodied within a form that does not provide all of the features and benefits set forth herein, as some features may be used or practiced separately from others. The scope of the inventions is indicated by the appended claims rather than by the foregoing description. All changes which come within the meaning and range of equivalency of the claims are to be embraced within their scope. For example, while the delivery system is described with respect to deploying a bifurcated stent in the abdominal aortic, it is further envisioned that the delivery system could be used to deliver a prosthesis having a main portion and at least one branch portion, or alternatively a prosthesis having only a straight, main branch portion, to other branched intravascular vessels (e.g., the thoracic aorta and a cardiac artery) and leave a guidewire positioned through the expanded prosthesis.

The term “guidewire” is to be interpreted broadly and may include, in addition to its ordinary and customary meaning to a person of ordinary skill in the art, any elongate member. Although the disclosure herein describes a locking assembly for reversibly coupling a guidewire to a delivery system, the locking assembly can also be used to reversibly couple any elongate structure to the delivery system, catheter, or otherwise.

As used herein, the relative terms “proximal” and “distal” shall be defined from the perspective of the delivery system. Thus, proximal refers to the direction of the control end of the delivery system and distal refers to the direction of the distal tip.

Note that the terms “first” and “second” branch portion can be used interchangeably and to refer to any branch vessel in the body, including but not limited to the ipsilateral vessel, the contralateral vessel, radial vessels, and subclavian vessels. Accordingly, in some embodiments, the “first” branch portion can refer to any branch portion including but not limited to the vessels set forth above. Similarly, the “second” branch portion can refer to any branch portion including but not limited to the vessels set forth below.

Conditional language, such as “can,” “could,” “might,” or “may,” unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements, and/or steps. Thus, such conditional language is not generally intended to imply that features, elements, and/or steps are in any way required for one or more embodiments.

The terms “comprising,” “including,” “having,” and the like are synonymous and are used inclusively, in an open-ended fashion, and do not exclude additional elements, features, acts, operations, and so forth. Also, the term “or” is used in its inclusive sense (and not in its exclusive sense) so that when used, for example, to connect a list of elements, the term “or” means one, some, or all of the elements in the list.

The terms “approximately,” “about,” “generally,” and “substantially” as used herein represent an amount close to the stated amount that still performs a desired function or achieves a desired result. For example, the terms “approximately”, “about”, and “substantially” may refer to an amount that is within less than 10% of the stated amount. As another example, in certain embodiments, the terms “substantially parallel” refer to a value, amount, or characteristic that departs from exactly parallel by less than or equal to 15 degrees.

The ranges disclosed herein also encompass any and all overlap, sub-ranges, and combinations thereof. Language such as “up to,” “at least,” “greater than,” “less than,” “between” and the like includes the number recited. Numbers preceded by a term such as “about” or “approximately” include the recited numbers. For example, “approximately 2 in.” includes “2 in.”

Some embodiments have been described in connection with the accompanying drawings. However, it should be understood that the figures are not drawn to scale. Distances, angles, etc. are merely illustrative and do not necessarily bear an exact relationship to actual dimensions and layout of the devices illustrated. Components can be added, removed, and/or rearranged. Further, the disclosure herein of any particular feature, aspect, method, property, characteristic, quality, attribute, element, or the like in connection with various embodiments can be used in all other embodiments set forth herein. Additionally, it will be recognized that any methods described herein may be practiced using any device suitable for performing the recited steps.

For purposes of this disclosure, certain aspects, advantages, and novel features are described herein. It is to be understood that not necessarily all such advantages may be achieved in accordance with any particular embodiment. Thus, for example, those skilled in the art will recognize that the disclosure may be embodied or carried out in a manner that achieves one advantage or a group of advantages as taught herein without necessarily achieving other advantages as may be taught or suggested herein.

Moreover, while illustrative embodiments have been described herein, the scope of any and all embodiments having equivalent elements, modifications, omissions, combinations (e.g., of aspects across various embodiments), adaptations and/or alterations as would be appreciated by those in the art based on the present disclosure. The limitations in the claims are to be interpreted broadly based on the language employed in the claims and not limited to the examples described in the present specification or during the prosecution of the application, which examples are to be construed as non-exclusive. Further, the actions of the disclosed processes and methods may be modified in any manner, including by reordering actions and/or inserting additional actions and/or deleting actions. It is intended, therefore, that the specification and examples be considered as illustrative only, with a true scope and spirit being indicated by the claims and their full scope of equivalents.

Any methods disclosed herein need not be performed in the order recited. The methods disclosed herein include certain actions taken by a practitioner; however, they can also include any third-party instruction of those actions, either expressly or by implication. For example, actions such as “releasing the delivery system from the locked configuration” include “instructing release of the delivery system from the locked configuration.”

Example Embodiments

The following example embodiments identify some possible permutations of combinations of features disclosed herein, although other permutations of combinations of features are also possible.

1. A locking assembly for releasably coupling a first elongate structure to a second elongate structure, the locking assembly comprising:

- a housing comprising a proximal end, a distal end, and a lateral wall portion;
- a first lumen extending from the proximal end of the housing to the distal end of the housing and along a longitudinal axis of the locking assembly, the first lumen being configured to receive the first elongate structure;
- a second lumen extending from the distal end of the housing, a diameter of the second lumen being less than a diameter of the first lumen, the second lumen being configured to receive the second elongate structure; and
- a recessed portion extending at least partially through the housing, the recessed portion comprising at least one opening in the lateral wall portion of the housing.

2. The locking assembly of Embodiment 1, further comprising an elastomeric member in the recessed portion, the elastomeric member configured to retain the second elongate structure when the second elongate structure extends through the second lumen.

3. The locking assembly of Embodiment 2, wherein at least a portion of an outer surface of the elastomeric member is substantially flush with an outer surface of the lateral wall portion of the housing.

4. The locking assembly of Embodiment 2, or 3 wherein the elastomeric member comprises an opening at least partially aligned with the second lumen.

5. The locking assembly of Embodiment 4, wherein the opening comprises a diameter that is smaller than the diameter of the second lumen.

6. The locking assembly of any one of Embodiments 2 to 5, wherein the elastomeric member comprises silicone.

7. The locking assembly of any one of the preceding Embodiments, wherein a proximal portion of the housing is tapered.

8. The locking assembly of any one of the preceding Embodiments, further comprising a protruding portion extending along at least a portion of an outer periphery of a distal portion of the housing.

9. The locking assembly of Embodiment 8, wherein the second lumen is positioned between the first lumen and the protruding portion.

10. The locking assembly of any one of the preceding Embodiments, wherein the second lumen comprises a proximal portion, a distal portion, and an intermediate portion therebetween, a diameter of the intermediate portion being less than a diameter of the proximal portion and the distal portion.

11. A locking assembly for coupling a contralateral guidewire to an ipsilateral catheter, the locking assembly comprising:

- an anchoring portion configured to engage the ipsilateral catheter; and
- an interlock portion configured to retain a distal portion of the contralateral guidewire when the contralateral guidewire is advanced or retracted unless a vertical force of at least 0.1 lbf is applied to the contralateral guidewire.

12. The locking assembly of Embodiment 11, wherein the interlock portion comprises a lumen, the lumen being shaped to retain the contralateral guidewire when the contralateral guidewire is retracted.

13. The locking assembly of Embodiment 12, wherein the lumen comprises a distal portion, a proximal portion, and an intermediate portion therebetween, a diameter of the intermediate portion being less than a diameter of the distal portion and a diameter of the proximal portion.

14. The locking assembly of any one of Embodiments 11 to 13, further comprising a retention member configured to frictionally retain the guidewire when the guidewire is advanced.

15. The locking assembly of Embodiment 14, wherein the retention member comprises an elastomeric material.

16. The locking assembly of Embodiment 14 or 15, wherein the retention member comprises an opening configured to receive the contralateral guidewire.

17. The locking assembly of any one of Embodiments 11 to 16, wherein the interlock portion is configured to release the contralateral guidewire when a force is applied to an intermediate portion of the contralateral guidewire at an angle of less than or equal to about 60 degrees from the distal portion of the guidewire in the interlock portion.

18. A system for reversibly securing a first elongate member to a second elongate member, the system comprising:

- a first elongate member;
- a second elongate member comprising a proximal portion and a distal portion; and
- a locking assembly fixed to the first elongate member, the locking assembly comprising:
  - a housing comprising a proximal end and a distal end;
  - a lumen extending from the distal end of the housing and through at least a portion of the housing, the second lumen being configured to receive the second elongate member from a distal side of the locking assembly;
  - a recessed portion extending at least partially through the housing; and
  - an elastomeric member in the recessed portion, the elastomeric member configured to retain the distal portion of the second elongate member when the second elongate member extends through the second lumen.

19. The system of Embodiment 18, wherein the second elongate member comprises a first region and a second region, the first region having a first stiffness, the second region having a second stiffness, the first stiffness being greater than the second stiffness.

20. The system of Embodiment 19, wherein the first region is distal to the second region.

21. The system of Embodiment 19, wherein the first region is at a distal end of the second elongate member.

22. The system of Embodiment 18 or 19, further comprising a sheath configured to be advanced along the second elongate member and disengage the second elongate member from the recessed portion.

23. The system of Embodiment 18 to 22, wherein the second elongate member is a guidewire.

24. The system of any one of Embodiments 18 to 23, wherein the first elongate member is a catheter.

25. The system of any one of Embodiments 18 to 24, wherein the second lumen comprises a proximal portion, a distal portion, and an intermediate portion therebetween, a diameter of the intermediate portion being less than a diameter of the distal portion and a diameter of the proximal portion.

26. The system of any one of Embodiments 18 to 25, wherein the recessed portion comprises at least one opening in a lateral wall of the housing.

27. The system of any one of Embodiments 18 to 26, wherein the elastomeric member comprises an opening at least partially aligned with the second lumen.

28. The locking assembly of Embodiment 27, wherein the opening comprises a diameter that is smaller than the diameter of the second lumen.

29. The locking assembly of any one of Embodiments 18 to 28, wherein the elastomeric member comprises silicone.

30. The locking assembly of any one of Embodiments 18 to 29, further comprising a protruding portion extending along at least a portion of an outer periphery of a distal portion of the housing.

31. A method for releasing a contralateral guidewire from an ipsilateral catheter, the method comprising:

- advancing a delivery system in a locked configuration, the delivery system comprising a locking assembly fixed to the ipsilateral catheter, the locking assembly comprising an interlock portion configured to retain the guidewire when the delivery system is in the locked configuration, a distal end of the guidewire being introduced into the interlock portion from a distal side of the locking assembly such that the guidewire comprises a bend when the delivery system is in the locked configuration, the bend being positioned between a proximal portion of the guidewire and the distal portion of the guidewire; and
- releasing the delivery system from the locked configuration to the unlocked configuration by advancing a release catheter along the guidewire.

32. The method of Embodiment 31, wherein in the locked configuration, the interlock portion is configured to retain the guidewire when the guidewire is retracted.

33. The method of Embodiment 31 or 32, wherein before advancing the release catheter, the interlock portion is configured to retain the guidewire when the guidewire is advanced.

34. The method of any one of Embodiments 31 to 33, wherein releasing the delivery system comprises applying a force to the guidewire at an angle of less than or equal to about 60 degrees from a longitudinal axis of the locking assembly.

Claims

1. A locking assembly for releasably coupling a first elongate structure to a second elongate structure, the locking assembly comprising: a housing comprising a proximal end, a distal end, and a lateral wall portion;a first lumen extending from the proximal end of the housing to the distal end of the housing and along a longitudinal axis of the locking assembly, the first lumen being configured to receive the first elongate structure;a second lumen extending from the distal end of the housing, a diameter of the second lumen being less than a diameter of the first lumen, the second lumen being configured to receive the second elongate structure;a recessed portion extending at least partially through the housing, the recessed portion comprising at least one opening in the lateral wall portion of the housing; andan elastomeric member in the recessed portion configured to retain the second elongate structure when the second elongate structure extends through the second lumen.
2. The locking assembly of claim 1, wherein at least a portion of an outer surface of the elastomeric member is substantially flush with an outer surface of the lateral wall portion of the housing.
3. The locking assembly of claim 1, wherein the elastomeric member comprises an opening at least partially aligned with the second lumen.
4. The locking assembly of claim 3, wherein the opening comprises a diameter that is smaller than the diameter of the second lumen.
5. The locking assembly of claim 1, wherein the elastomeric member comprises silicone.
6. The locking assembly of claim 1, wherein a proximal portion of the housing is tapered.
7. The locking assembly of claim 1, further comprising a protruding portion extending along at least a portion of an outer periphery of a distal portion of the housing.
8. The locking assembly of claim 7, wherein the second lumen is positioned between the first lumen and the protruding portion.
9. The locking assembly of claim 1, wherein the second lumen comprises a proximal portion, a distal portion, and an intermediate portion therebetween, a diameter of the intermediate portion being less than a diameter of the proximal portion and the distal portion.
10. A locking assembly for coupling a contralateral guidewire to an ipsilateral catheter, the locking assembly comprising: the contralateral guidewire;the ipsilateral catheter;an anchoring portion configured to engage the ipsilateral catheter; andan interlock portion configured to retain a distal portion of the contralateral guidewire when the contralateral guidewire is advanced or retracted unless a vertical force of at least 0.1 lbf is applied to the contralateral guidewirewherein the assembly comprises a retention member configured to frictionally retain the contralateral guidewire when the contralateral guidewire is advanced; anda sheath configured to be advanced along the contralateral guidewire and disengage the contralateral guidewire from the retention member.
11. The locking assembly of claim 10, wherein the interlock portion comprises a lumen, the lumen being shaped to retain the contralateral guidewire when the contralateral guidewire is retracted.
12. The locking assembly of claim 11, wherein the lumen comprises a distal portion, a proximal portion, and an intermediate portion therebetween, a diameter of the intermediate portion being less than a diameter of the distal portion and a diameter of the proximal portion.
13. The locking assembly of claim 10, wherein the retention member comprises an elastomeric material.
14. The locking assembly of claim 10, wherein the retention member comprises an opening configured to receive the contralateral guidewire.
15. The locking assembly of claim 10, wherein the interlock portion is configured to release the contralateral guidewire when a force is applied to an intermediate portion of the contralateral guidewire at an angle of less than or equal to about 60 degrees from the distal portion of the guidewire in the interlock portion.
16. A system for reversibly securing a first elongate member to a second elongate member, the system comprising: the first elongate member; andthe second elongate member comprising a proximal portion and a distal portion;a locking assembly fixed to the first elongate member, the locking assembly comprising:a housing comprising a proximal end and a distal end;a lumen extending from the distal end of the housing and through at least a portion of the housing, the lumen being configured to receive the second elongate member from a distal side of the locking assembly;a recessed portion extending at least partially through the housing; and an elastomeric member in the recessed portion, the elastomeric member configured to retain the distal portion of the second elongate member when the second elongate member extends through the lumen;a sheath configured to be advanced along the second elongate member to disengage the second elongate member from the recessed portion.
17. The system of claim 16, wherein the second elongate member comprises a first region and a second region, the first region having a first stiffness, the second region having a second stiffness, the first stiffness being greater than the second stiffness.
18. The system of claim 17, wherein the first region is distal to the second region.
19. The system of claim 17, wherein the first region is at a distal end of the second elongate member.
20. The system of claim 16, wherein the second elongate member is a guidewire.
21. The system of claim 20, wherein the first elongate member is a catheter.
22. The system of claim 16, wherein the lumen comprises a proximal portion, a distal portion, and an intermediate portion therebetween, a diameter of the intermediate portion being less than a diameter of the distal portion and a diameter of the proximal portion.
23. The system of claim 16, wherein the recessed portion comprises at least one opening in a lateral wall of the housing.
24. The system of claim 16, wherein the elastomeric member comprises an opening at least partially aligned with the lumen.
25. The locking assembly of claim 24, wherein the opening comprises a diameter that is smaller than the diameter of the lumen.
26. The locking assembly of claim 16, wherein the elastomeric member comprises silicone.
27. The locking assembly of claim 16, further comprising a protruding portion extending along at least a portion of an outer periphery of a distal portion of the housing.

INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS

This application is a national phase filing of PCT Application No. PCT/US2016/040197, filed Jun. 29, 2016, which claims the benefit of U.S. Provisional Application No. 62/187,103, filed Jun. 30, 2015, which is hereby incorporated by reference in its entirety herein.

PCT Information

Filing Document	Filing Date	Country	Kind
PCT/US2016/040197	6/29/2016	WO	00

Publishing Document	Publishing Date	Country	Kind
WO2017/004265	1/5/2017	WO	A

US Referenced Citations (1215)

Number	Name	Date	Kind
519928	Schanck	May 1894	A
1065935	Gail	Jul 1913	A
2127903	Bowen	Aug 1938	A
2335333	Wysong	Nov 1943	A
2437542	Krippendorf	May 1944	A
2845959	Sidebotham	Aug 1958	A
2990605	Demsyk	Jul 1961	A
3029819	Starks	Apr 1962	A
3096560	Liebig	Jul 1963	A
3245703	Manly	Apr 1966	A
3805301	Liebig	Apr 1974	A
3994149	Dahlman	Nov 1976	A
4362156	Feller, Jr. et al.	Dec 1982	A
4402685	Bühler et al.	Sep 1983	A
4473067	Schiff	Sep 1984	A
4497074	Ray et al.	Feb 1985	A
4501263	Harbuck	Feb 1985	A
4503568	Madras	Mar 1985	A
4512338	Balko et al.	Apr 1985	A
4525157	Vaillancourt	Jun 1985	A
4562596	Kornberg	Jan 1986	A
4580568	Gianturco	Apr 1986	A
4592754	Gupte et al.	Jun 1986	A
4617932	Kornberg	Oct 1986	A
4723550	Bales et al.	Feb 1988	A
4723938	Goodin et al.	Feb 1988	A
4728328	Hughes et al.	Mar 1988	A
4747833	Kousai et al.	May 1988	A
4756307	Crownshield	Jul 1988	A
4768507	Fischell et al.	Sep 1988	A
4772266	Groshong	Sep 1988	A
4781690	Ishida et al.	Nov 1988	A
4795465	Marten	Jan 1989	A
4800882	Gianturco	Jan 1989	A
4816028	Kapadia et al.	Mar 1989	A
4840940	Sottiurai	Jun 1989	A
4856516	Hillstead	Aug 1989	A
4874374	Kousai et al.	Oct 1989	A
4878906	Lindemann et al.	Nov 1989	A
4888000	McQuilkin et al.	Dec 1989	A
4907336	Gianturco	Mar 1990	A
4917668	Haindl	Apr 1990	A
4922905	Strecker	May 1990	A
4960412	Fink	Oct 1990	A
4978334	Toye et al.	Dec 1990	A
4981478	Evard et al.	Jan 1991	A
4981947	Tomagou et al.	Jan 1991	A
4994069	Ritchrt et al.	Feb 1991	A
4994071	MacGregor	Feb 1991	A
5019090	Pinchuk	May 1991	A
5026377	Burton et al.	Jun 1991	A
5035706	Giantureo et al.	Jul 1991	A
5064414	Revane	Nov 1991	A
5064435	Porter	Nov 1991	A
5078726	Kreamer	Jan 1992	A
5084010	Plaia et al.	Jan 1992	A
5098392	Fleischhacker et al.	Mar 1992	A
5098395	Fields	Mar 1992	A
5104388	Quackenbush	Apr 1992	A
5104399	Lazarus	Apr 1992	A
5108380	Herlitze et al.	Apr 1992	A
5108424	Hoffman, Jr. et al.	Apr 1992	A
5116349	Aranyi	May 1992	A
5122154	Rhodes	Jun 1992	A
5123917	Lee	Jun 1992	A
5133732	Wiktor	Jul 1992	A
5135535	Kramer	Aug 1992	A
5135536	Hillstead	Aug 1992	A
5137519	Littrell et al.	Aug 1992	A
5141497	Erskine	Aug 1992	A
5151105	Kwan-Gett	Sep 1992	A
5156619	Ehrenfeld	Oct 1992	A
5158545	Trudell et al.	Oct 1992	A
5167634	Corrigan, Jr. et al.	Dec 1992	A
5178634	Martinez	Jan 1993	A
5186712	Kelso et al.	Feb 1993	A
5195978	Schiffer	Mar 1993	A
5195980	Catlin	Mar 1993	A
5197976	Herweck et al.	Mar 1993	A
5201757	Heyn et al.	Apr 1993	A
5203774	Gilson et al.	Apr 1993	A
5205829	Lituchy	Apr 1993	A
5211658	Clouse	May 1993	A
5222969	Gillis	Jun 1993	A
5242399	Lau et al.	Sep 1993	A
5246452	Sinnott	Sep 1993	A
5250036	Farivar	Oct 1993	A
5256141	Gancheff et al.	Oct 1993	A
5263932	Jang	Nov 1993	A
5267982	Sylvanowicz	Dec 1993	A
5273052	Kraus et al.	Dec 1993	A
5275622	Lazarus et al.	Jan 1994	A
5279592	Amor et al.	Jan 1994	A
5282478	Fleischhaker et al.	Feb 1994	A
5282824	Gianturco	Feb 1994	A
5282860	Matsuno et al.	Feb 1994	A
5290310	Makower et al.	Mar 1994	A
5304156	Sylvanowicz et al.	Apr 1994	A
5304200	Spaulding	Apr 1994	A
5314444	Gianturco	May 1994	A
5314472	Fontaine	May 1994	A
5316023	Palmaz et al.	May 1994	A
5320602	Karpeil	Jun 1994	A
5324306	Makower et al.	Jun 1994	A
5330500	Song	Jul 1994	A
5334157	Klein et al.	Aug 1994	A
5342387	Summers	Aug 1994	A
5350397	Palermo et al.	Sep 1994	A
5354308	Simon et al.	Oct 1994	A
5360443	Barone et al.	Nov 1994	A
5366504	Andersen et al.	Nov 1994	A
5370683	Fontaine	Dec 1994	A
5376077	Gomringer	Dec 1994	A
5383892	Cardon et al.	Jan 1995	A
5387235	Chuter	Feb 1995	A
5389087	Miraki	Feb 1995	A
5391152	Patterson	Feb 1995	A
5397310	Chu et al.	Mar 1995	A
5397355	Marin et al.	Mar 1995	A
5403283	Luther	Apr 1995	A
5403341	Solar	Apr 1995	A
5405323	Rogers et al.	Apr 1995	A
5405377	Cragg	Apr 1995	A
5405378	Strecker	Apr 1995	A
5414664	Lin et al.	May 1995	A
5415178	Hsi et al.	May 1995	A
5415664	Pinchuk	May 1995	A
5423886	Arru et al.	Jun 1995	A
5425765	Tiefenbrun et al.	Jun 1995	A
5443477	Marin et al.	Aug 1995	A
5443498	Fontaine	Aug 1995	A
5443500	Sigwart	Aug 1995	A
5453090	Martinez et al.	Sep 1995	A
5456713	Chuter	Oct 1995	A
5458615	Klemm et al.	Oct 1995	A
5462530	Jang	Oct 1995	A
5464449	Ryan et al.	Nov 1995	A
5464450	Buscemi et al.	Nov 1995	A
5464499	Moslehi et al.	Nov 1995	A
5472417	Martin et al.	Dec 1995	A
5484444	Braunschweiler et al.	Jan 1996	A
5489295	Piplani et al.	Feb 1996	A
5496365	Sgro	Mar 1996	A
5505710	Dorsey, III	Apr 1996	A
5507727	Crainich	Apr 1996	A
5507767	Maeda et al.	Apr 1996	A
5507768	Lau et al.	Apr 1996	A
5507769	Marin et al.	Apr 1996	A
5507771	Gianturco	Apr 1996	A
5522880	Barone et al.	Jun 1996	A
5522881	Lentz	Jun 1996	A
5522882	Gaterud et al.	Jun 1996	A
5522883	Slater et al.	Jun 1996	A
5523092	Slater et al.	Jun 1996	A
5545152	Funderburk et al.	Aug 1996	A
5545209	Roberts et al.	Aug 1996	A
5545211	An et al.	Aug 1996	A
5549635	Solar	Aug 1996	A
5545118	Jang	Sep 1996	A
5554118	Jang	Sep 1996	A
5554181	Das	Sep 1996	A
5562697	Christiansen	Oct 1996	A
5562724	Vorwerk et al.	Oct 1996	A
5562726	Chuter	Oct 1996	A
5562728	Lazarus et al.	Oct 1996	A
5571135	Fraser et al.	Nov 1996	A
5571169	Plaia et al.	Nov 1996	A
5571172	Chin	Nov 1996	A
5571173	Parodi	Nov 1996	A
5575816	Rudnick et al.	Nov 1996	A
5575817	Martin	Nov 1996	A
5575818	Pinchuk	Nov 1996	A
5578071	Parodi	Nov 1996	A
5578072	Barone et al.	Nov 1996	A
5591195	Taheri et al.	Jan 1997	A
5591197	Orth et al.	Jan 1997	A
5591198	Boyle et al.	Jan 1997	A
5591226	Trerotola et al.	Jan 1997	A
5591228	Edoga	Jan 1997	A
5591229	Parodi	Jan 1997	A
5591230	Horn et al.	Jan 1997	A
5593417	Rhodes	Jan 1997	A
5599305	Hermann et al.	Feb 1997	A
5604435	Foo et al.	Feb 1997	A
5607445	Summers	Mar 1997	A
5609625	Piplani et al.	Mar 1997	A
5609627	Goicoechea et al.	Mar 1997	A
5609628	Keranen	Mar 1997	A
5628755	Heller et al.	May 1997	A
5628783	Quiachon et al.	May 1997	A
5628786	Banas et al.	May 1997	A
5628788	Pinchuk	May 1997	A
5630829	Lauterjung	May 1997	A
5630830	Verbeek	May 1997	A
5632763	Glastra	May 1997	A
5632772	Alcime et al.	May 1997	A
5634928	Fischell et al.	Jun 1997	A
5639278	Dereume et al.	Jun 1997	A
5641373	Shannon et al.	Jun 1997	A
5643171	Bradshaw et al.	Jul 1997	A
5643278	Wijay	Jul 1997	A
5643339	Kavteladze et al.	Jul 1997	A
5647857	Anderson et al.	Jul 1997	A
5649952	Lam	Jul 1997	A
5651174	Schwartz et al.	Jul 1997	A
5653727	Wiktor	Aug 1997	A
5653743	Martin	Aug 1997	A
5653746	Schmitt	Aug 1997	A
5653747	Dereume	Aug 1997	A
5653748	Strecker	Aug 1997	A
5662580	Bradshaw et al.	Sep 1997	A
5662614	Edoga	Sep 1997	A
5662675	Polanskyj Stockert et al.	Sep 1997	A
5662700	Lazarus	Sep 1997	A
5662701	Plaia et al.	Sep 1997	A
5662702	Keranen	Sep 1997	A
5662703	Yurek et al.	Sep 1997	A
5665115	Cragg	Sep 1997	A
5665117	Rhodes	Sep 1997	A
5666968	Imran et al.	Sep 1997	A
5669880	Solar	Sep 1997	A
5669924	Shaknovich	Sep 1997	A
5669934	Sawyer	Sep 1997	A
5674241	Bley et al.	Oct 1997	A
5674276	Andersen et al.	Oct 1997	A
5676671	Inoue	Oct 1997	A
5676685	Razaivi	Oct 1997	A
5676696	Marcade	Oct 1997	A
5676697	McDonald	Oct 1997	A
5679400	Tuch	Oct 1997	A
5681345	Tuteneuer	Oct 1997	A
5681346	Orth et al.	Oct 1997	A
5683448	Cragg	Nov 1997	A
5683449	Marcade	Nov 1997	A
5683450	Goicoechea et al.	Nov 1997	A
5683451	Lenker et al.	Nov 1997	A
5683452	Barone et al.	Nov 1997	A
5683453	Palmaz	Nov 1997	A
5690642	Osborne et al.	Nov 1997	A
5690643	Wijay	Nov 1997	A
5690644	Yurek et al.	Nov 1997	A
5690671	McGurk et al.	Nov 1997	A
5693015	Walker et al.	Dec 1997	A
5693066	Rupp et al.	Dec 1997	A
5693084	Chuter	Dec 1997	A
5693086	Goicoechea et al.	Dec 1997	A
5693087	Parodi	Dec 1997	A
5693088	Lazarus	Dec 1997	A
5695516	Fischell et al.	Dec 1997	A
5695517	Marin et al.	Dec 1997	A
5697948	Marin et al.	Dec 1997	A
5697971	Fischell et al.	Dec 1997	A
5700269	Pinchuk et al.	Dec 1997	A
5702418	Ravenscroft	Dec 1997	A
5707354	Salmon et al.	Jan 1998	A
5709703	Lukic et al.	Jan 1998	A
5713917	Leonhardt	Feb 1998	A
5716365	Goicoechea et al.	Feb 1998	A
5716393	Lindenberg et al.	Feb 1998	A
5718724	Goicoechea et al.	Feb 1998	A
5718973	Lewis et al.	Feb 1998	A
5720735	Dorros	Feb 1998	A
5720776	Chuter et al.	Feb 1998	A
5723004	Dereume et al.	Mar 1998	A
5725519	Penner et al.	Mar 1998	A
5733267	Del Toro	Mar 1998	A
5733325	Robinson et al.	Mar 1998	A
5738660	Luther	Apr 1998	A
5738674	Williams et al.	Apr 1998	A
5741233	Riddle et al.	Apr 1998	A
5741325	Chaikof et al.	Apr 1998	A
5746766	Edoga	May 1998	A
5746776	Smith et al.	May 1998	A
5749880	Banas et al.	May 1998	A
5749921	Lenker et al.	May 1998	A
5755735	Richter et al.	May 1998	A
5755770	Ravenscroft	May 1998	A
5755771	Penn et al.	May 1998	A
5755777	Chuter	May 1998	A
5765682	Bley et al.	Jun 1998	A
5766203	Imran et al.	Jun 1998	A
5769882	Fogarty et al.	Jun 1998	A
5769885	Quiachon et al.	Jun 1998	A
5769887	Brown et al.	Jun 1998	A
5772636	Brimhall et al.	Jun 1998	A
5782807	Falvai et al.	Jun 1998	A
5776142	Gunderson	Jul 1998	A
5782817	Franzel et al.	Jul 1998	A
5782855	Lau et al.	Jul 1998	A
5782909	Quiachon et al.	Jul 1998	A
5788707	Del Toro et al.	Aug 1998	A
5797952	Klein	Aug 1998	A
5800456	Maeda et al.	Sep 1998	A
5800508	Goicoechea et al.	Sep 1998	A
5800514	Nunez et al.	Sep 1998	A
5800517	Anderson et al.	Sep 1998	A
5800526	Anderson et al.	Sep 1998	A
5800540	Chin	Sep 1998	A
5810836	Hussein et al.	Sep 1998	A
5810873	Morales	Sep 1998	A
5817100	Igaki	Oct 1998	A
5823198	Jones et al.	Oct 1998	A
5824037	Fogarty et al.	Oct 1998	A
5824039	Piplani et al.	Oct 1998	A
5824040	Cox et al.	Oct 1998	A
5824041	Lenker et al.	Oct 1998	A
5824053	Khosravi et al.	Oct 1998	A
5843046	Motisi et al.	Dec 1998	A
5843092	Heller et al.	Dec 1998	A
5843160	Rhodes	Dec 1998	A
5843162	Inoue	Dec 1998	A
5843164	Frantzen et al.	Dec 1998	A
5843167	Dwyer	Dec 1998	A
5851228	Pinheiro	Dec 1998	A
5855599	Wan	Jan 1999	A
5855600	Alt	Jan 1999	A
5860998	Robinson et al.	Jan 1999	A
5865844	Plaia et al.	Feb 1999	A
5867432	Toda	Feb 1999	A
5868783	Tower	Feb 1999	A
5871536	Lazarus	Feb 1999	A
5873906	Lau et al.	Feb 1999	A
5876432	Lau et al.	Mar 1999	A
5879321	Hill	Mar 1999	A
5879333	Smith	Mar 1999	A
5879334	Brimhall	Mar 1999	A
5879366	Shaw et al.	Mar 1999	A
5885217	Gisselberg et al.	Mar 1999	A
5891193	Robinson et al.	Apr 1999	A
5893868	Hanson et al.	Apr 1999	A
5893887	Jayaraman	Apr 1999	A
5902334	Dwyer et al.	May 1999	A
5906619	Olson et al.	May 1999	A
5906640	Penn et al.	May 1999	A
5906641	Thompson et al.	May 1999	A
5910145	Fischell et al.	Jun 1999	A
5911710	Barry et al.	Jun 1999	A
5911752	Dustrude et al.	Jun 1999	A
5916263	Goicoceha et al.	Jun 1999	A
5919225	Lau et al.	Jul 1999	A
5925075	Myers et al.	Jul 1999	A
5925076	Inoue	Jul 1999	A
5928248	Acker	Jul 1999	A
5928279	Shannon et al.	Jul 1999	A
5935135	Bramfitt et al.	Aug 1999	A
5935161	Robinson et al.	Aug 1999	A
5938696	Goicoechea et al.	Aug 1999	A
5948017	Taheri	Sep 1999	A
5948018	Dereume et al.	Sep 1999	A
5954729	Bachmann et al.	Sep 1999	A
5957929	Brenneman	Sep 1999	A
5957949	Leonhardt et al.	Sep 1999	A
5957973	Quiachon et al.	Sep 1999	A
5961546	Robinson et al.	Oct 1999	A
5961548	Shmulewitz	Oct 1999	A
5971958	Zhang	Oct 1999	A
5976153	Fischell et al.	Nov 1999	A
5976155	Foreman et al.	Nov 1999	A
5980514	Kupiecki et al.	Nov 1999	A
5984929	Bashiri et al.	Nov 1999	A
5984955	Wisselink	Nov 1999	A
5989242	Saadat et al.	Nov 1999	A
5993489	Lewis et al.	Nov 1999	A
5997562	Zadno-Azizi et al.	Dec 1999	A
6001125	Golds et al.	Dec 1999	A
6004294	Brimhall et al.	Dec 1999	A
6004347	McNamara et al.	Dec 1999	A
6004348	Banas et al.	Dec 1999	A
6017363	Hojeibane	Jan 2000	A
6019777	Mackenzie	Feb 2000	A
6019785	Strecker	Feb 2000	A
6027508	Ren et al.	Feb 2000	A
6027520	Tsugita et al.	Feb 2000	A
6027779	Campbell et al.	Feb 2000	A
6027811	Campbell et al.	Feb 2000	A
6030414	Taheri	Feb 2000	A
6030415	Chuter	Feb 2000	A
6033413	Mikus et al.	Mar 2000	A
6033434	Borghi	Mar 2000	A
6039749	Marin et al.	Mar 2000	A
6039755	Edwin et al.	Mar 2000	A
6039758	Quiachon et al.	Mar 2000	A
6045557	White et al.	Apr 2000	A
6051020	Goicoechea et al.	Apr 2000	A
6053940	Wijay	Apr 2000	A
6056722	Jayaraman	May 2000	A
6059813	Vrba et al.	May 2000	A
6059824	Taheri	May 2000	A
6063092	Shin	May 2000	A
6063113	Kavteladze et al.	May 2000	A
6068635	Gianotti	May 2000	A
6068654	Berg et al.	May 2000	A
6070589	Keith et al.	Jun 2000	A
6074398	Leschinsky	Jun 2000	A
6077295	Limon et al.	Jun 2000	A
6077296	Shokoohi et al.	Jun 2000	A
6077297	Robinson et al.	Jun 2000	A
6080191	Summers	Jun 2000	A
6086611	Duffy et al.	Jul 2000	A
6090128	Douglas	Jul 2000	A
6090135	Plaia et al.	Jul 2000	A
6093194	Mikus et al.	Jul 2000	A
6093203	Uflacker	Jul 2000	A
6096005	Botich et al.	Aug 2000	A
6096027	Layne	Aug 2000	A
6106548	Reubin et al.	Aug 2000	A
6110180	Foreman et al.	Aug 2000	A
6113607	Lau et al.	Sep 2000	A
6117142	Goodson et al.	Sep 2000	A
6117167	Goicoechea et al.	Sep 2000	A
6123722	Fogarty et al.	Sep 2000	A
6123723	Konya	Sep 2000	A
6126685	Lenker et al.	Oct 2000	A
6129756	Kugler et al.	Oct 2000	A
6132458	Stachle et al.	Oct 2000	A
6136006	Johnson et al.	Oct 2000	A
6139532	Howell et al.	Oct 2000	A
6143002	Vietmeier	Nov 2000	A
6143016	Bleam et al.	Nov 2000	A
6146389	Geitz	Nov 2000	A
6146415	Fitz	Nov 2000	A
6149680	Shelso et al.	Nov 2000	A
6149681	Houser et al.	Nov 2000	A
6152944	Holman et al.	Nov 2000	A
6156063	Douglas	Dec 2000	A
6159195	Ha et al.	Dec 2000	A
6159198	Gardeski et al.	Dec 2000	A
6162237	Chan	Dec 2000	A
6165195	Wilson et al.	Dec 2000	A
6165214	Lazarus	Dec 2000	A
6168610	Marin et al.	Jan 2001	B1
6171281	Zhang	Jan 2001	B1
6174327	Mertens et al.	Jan 2001	B1
6174329	Mertens et al.	Jan 2001	B1
6183443	Kratoska et al.	Feb 2001	B1
6183481	Lee et al.	Feb 2001	B1
6183509	Dibie	Feb 2001	B1
6187015	Brenneman	Feb 2001	B1
6187033	Schmitt et al.	Feb 2001	B1
6187036	Shaolian et al.	Feb 2001	B1
6187037	Satz	Feb 2001	B1
6192944	Greenhalgh	Feb 2001	B1
6193726	Vanney	Feb 2001	B1
6193745	Fogarty et al.	Feb 2001	B1
6197007	Thorne et al.	Mar 2001	B1
6197016	Fourkas et al.	Mar 2001	B1
6197049	Shaolian et al.	Mar 2001	B1
6203735	Edwin et al.	Mar 2001	B1
6210422	Douglas	Apr 2001	B1
6210429	Vardi et al.	Apr 2001	B1
6214038	Piplani et al.	Apr 2001	B1
6221081	Mikus et al.	Apr 2001	B1
6221090	Wilson	Apr 2001	B1
6221098	Wilson	Apr 2001	B1
6221102	Baker et al.	Apr 2001	B1
6224609	Ressemann et al.	May 2001	B1
6224627	Armstrong et al.	May 2001	B1
6228062	Howell et al.	May 2001	B1
6231543	Hegde	May 2001	B1
6231563	White et al.	May 2001	B1
6235051	Murphy	May 2001	B1
6238410	Vrba et al.	May 2001	B1
6254609	Vrba et al.	Jul 2001	B1
6254628	Wallace et al.	Jul 2001	B1
6258099	Mareiro et al.	Jul 2001	B1
6261316	Shaolian et al.	Jul 2001	B1
6264682	Wilson et al.	Jul 2001	B1
6273895	Pinchuk et al.	Aug 2001	B1
6273909	Kugler et al.	Aug 2001	B1
6280465	Cryer	Aug 2001	B1
6280466	Kugler et al.	Aug 2001	B1
6280467	Leonhardt	Aug 2001	B1
6283991	Cox et al.	Sep 2001	B1
6287315	Wijeratne et al.	Sep 2001	B1
6287329	Duering et al.	Sep 2001	B1
6296622	Kurz et al.	Oct 2001	B1
6299634	Bergeron	Oct 2001	B1
6302893	Limon et al.	Oct 2001	B1
6312406	Jayaraman	Nov 2001	B1
6315792	Armstrong et al.	Nov 2001	B1
6325826	Vardi et al.	Dec 2001	B1
6331184	Abrams	Dec 2001	B1
6331190	Shokoohi et al.	Dec 2001	B1
6334867	Anson	Jan 2002	B1
6344056	Dehdashtian	Feb 2002	B1
6346118	Baker et al.	Feb 2002	B1
6348066	Pinchuk et al.	Feb 2002	B1
6350278	Lenker et al.	Feb 2002	B1
6352553	Van der Burg et al.	Mar 2002	B1
6352554	De Paulis	Mar 2002	B2
6352561	Leopold et al.	Mar 2002	B1
6355060	Lenker et al.	Mar 2002	B1
6361544	Wilson et al.	Mar 2002	B1
6361555	Wilson	Mar 2002	B1
6361557	Gittings et al.	Mar 2002	B1
6361559	Houser et al.	Mar 2002	B1
6361637	Martin et al.	Mar 2002	B2
6379365	Diaz	Apr 2002	B1
6380457	Yurek et al.	Apr 2002	B1
6383213	Wilson et al.	May 2002	B2
6387120	Wilson et al.	May 2002	B2
6395017	Dwyer et al.	May 2002	B1
6395018	Castaneda	May 2002	B1
6395019	Chobotov	May 2002	B2
6398807	Chouinard et al.	Jun 2002	B1
6409750	Hyodoh et al.	Jun 2002	B1
6409757	Trout, III et al.	Jun 2002	B1
6416474	Penner et al.	Jul 2002	B1
6416529	Holman et al.	Jul 2002	B1
6416542	Marcade et al.	Jul 2002	B1
6425765	Irwin, III	Jul 2002	B1
6428565	Wisselink	Aug 2002	B1
6428567	Wilson et al.	Aug 2002	B2
6432130	Hanson	Aug 2002	B1
6432131	Ravenscroft	Aug 2002	B1
6432134	Anson et al.	Aug 2002	B1
6436135	Goldfarb	Aug 2002	B1
6440161	Madrid et al.	Aug 2002	B1
6447540	Fontaine et al.	Sep 2002	B1
6451043	McInnes et al.	Sep 2002	B1
6482211	Choi	Sep 2002	B1
6458152	Khosravi et al.	Oct 2002	B1
6464721	Marcade et al.	Oct 2002	B1
6468298	Pelton	Oct 2002	B1
6475166	Escano	Nov 2002	B1
6475170	Doron et al.	Nov 2002	B1
6478777	Honeck et al.	Nov 2002	B1
6485513	Fan	Nov 2002	B1
6491719	Fogrty et al.	Dec 2002	B1
6500182	Foster	Dec 2002	B2
6500202	Shaolian et al.	Dec 2002	B1
6508790	Lawrence	Jan 2003	B1
6508833	Pavcnick et al.	Jan 2003	B2
6508835	Shaolian et al.	Jan 2003	B1
6508836	Wilson et al.	Jan 2003	B2
6511325	Lalka et al.	Jan 2003	B1
6514281	Blaeser et al.	Feb 2003	B1
6514282	Inoue	Feb 2003	B1
6517522	Bell et al.	Feb 2003	B1
6517569	Mikus et al.	Feb 2003	B2
6517572	Kugler et al.	Feb 2003	B2
6517573	Pollock et al.	Feb 2003	B1
6520988	Colombo et al.	Feb 2003	B1
6524335	Hartley et al.	Feb 2003	B1
6524336	Papazolgou et al.	Feb 2003	B1
6533811	Ryan et al.	Mar 2003	B1
6544278	Vrba et al.	Apr 2003	B1
6551350	Thornton et al.	Apr 2003	B1
6554848	Boylan et al.	Apr 2003	B2
6558396	Inoue	May 2003	B1
6562063	Euteneurer et al.	May 2003	B1
6562064	Debeer	May 2003	B1
6565596	White et al.	May 2003	B1
6565597	Fearnot et al.	May 2003	B1
6569192	Foreman et al.	May 2003	B1
RE38146	Palmaz et al.	Jun 2003	E
6572643	Gharibadeh	Jun 2003	B1
6572645	Leonhardt	Jun 2003	B2
6576005	Geitz	Jun 2003	B1
6576006	Limon et al.	Jun 2003	B2
6576009	Ryan et al.	Jun 2003	B2
6579308	Jansen et al.	Jun 2003	B1
6579312	Wilson et al.	Jun 2003	B2
6582390	Sanderson	Jun 2003	B1
6582394	Reiss et al.	Jun 2003	B1
6582459	Lau et al.	Jun 2003	B1
6582460	Cryer	Jun 2003	B1
6585758	Chouinard et al.	Jul 2003	B1
6589213	Reydel	Jul 2003	B2
6589251	Yee et al.	Jul 2003	B2
6589262	Honebrink et al.	Jul 2003	B1
6592548	Jayaraman	Jul 2003	B2
6592581	Bowe	Jul 2003	B2
6592614	Lenker et al.	Jul 2003	B2
6592615	Marcade et al.	Jul 2003	B1
6599315	Wilson	Jul 2003	B2
6602280	Chobotov	Aug 2003	B2
6607551	Sullivan et al.	Aug 2003	B1
6607552	Hanson	Aug 2003	B1
6613073	White et al.	Sep 2003	B1
6613075	Healy et al.	Sep 2003	B1
6616675	Evard et al.	Sep 2003	B1
6620191	Svensson	Sep 2003	B1
6641564	Kraus	Nov 2003	B1
6645242	Quinn	Nov 2003	B1
6652492	Bell et al.	Nov 2003	B1
6652567	Deaton	Nov 2003	B1
6652579	Cox et al.	Nov 2003	B1
6656213	Solem	Dec 2003	B2
6660030	Shaolian et al.	Dec 2003	B2
6660033	Marcade et al.	Dec 2003	B1
6663665	Shaolian et al.	Dec 2003	B2
6669716	Gilson et al.	Dec 2003	B1
6669718	Besselink	Dec 2003	B2
6669719	Wallace et al.	Dec 2003	B2
6673102	Vonesh et al.	Jan 2004	B1
6676666	Vrba et al.	Jan 2004	B2
6676667	Mareiro et al.	Jan 2004	B2
6689157	Madrid et al.	Feb 2004	B2
6692483	Vardi et al.	Feb 2004	B2
6695875	Stelter et al.	Feb 2004	B2
6699274	Stinson	Mar 2004	B2
6699275	Knudson et al.	Mar 2004	B1
6702843	Brown et al.	Mar 2004	B1
6702845	Cully et al.	Mar 2004	B1
6706062	Vardi et al.	Mar 2004	B2
6722705	Korkor	Apr 2004	B2
6723075	Davey et al.	Apr 2004	B2
6723116	Taheri	Apr 2004	B2
6733523	Shaolian et al.	May 2004	B2
6740101	Houser et al.	May 2004	B2
6743210	Hart et al.	Jun 2004	B2
6749627	Thompson et al.	Jun 2004	B2
6752819	Brady et al.	Jun 2004	B1
6755855	Yurek et al.	Jun 2004	B2
6761733	Chobotov et al.	Jul 2004	B2
6767359	Weadock	Jul 2004	B2
6773457	Ivancev et al.	Aug 2004	B2
6790224	Gerberding	Sep 2004	B2
6793671	Wall	Sep 2004	B2
6800065	Duane et al.	Oct 2004	B2
6802859	Pazienza et al.	Oct 2004	B1
6808509	Davey	Oct 2004	B1
6808520	Fourkas et al.	Oct 2004	B1
6811566	Penn et al.	Nov 2004	B1
6814752	Chuter	Nov 2004	B1
6818014	Brown et al.	Nov 2004	B2
6821292	Pazienza et al.	Nov 2004	B2
6827706	Parodi	Dec 2004	B2
6827726	Parodi	Dec 2004	B2
6827731	Armstrong et al.	Dec 2004	B2
6833003	Jones et al.	Dec 2004	B2
6835203	Vardi et al.	Dec 2004	B1
6840950	Standford et al.	Jan 2005	B2
6846316	Abrams	Jan 2005	B2
6849084	Rabkin et al.	Feb 2005	B2
6849086	Cragg	Feb 2005	B2
6858038	Heuser	Feb 2005	B2
6866669	Buzzard et al.	Mar 2005	B2
6872193	Shaw et al.	Mar 2005	B2
6875229	Wilson et al.	Apr 2005	B2
6878158	Shin et al.	Apr 2005	B2
6887249	Houser et al.	May 2005	B1
6887251	Suval	May 2005	B1
6887256	Gilson et al.	May 2005	B2
6889026	Schlageter et al.	May 2005	B2
6896699	Wilson et al.	May 2005	B2
6899727	Armstrong et al.	May 2005	B2
6899728	Phillips et al.	May 2005	B1
6905505	Nash et al.	Jun 2005	B2
6908477	McGuckin	Jun 2005	B2
6911039	Shiu et al.	Jun 2005	B2
6918925	Tehrani	Jul 2005	B2
6923829	Boyle et al.	Aug 2005	B2
6926732	Derus et al.	Aug 2005	B2
6929661	Bolduc et al.	Aug 2005	B2
6932837	Amplatz et al.	Aug 2005	B2
6939327	Hall et al.	Sep 2005	B2
6939352	Buzzard et al.	Sep 2005	B2
6939368	Simso	Sep 2005	B2
6939370	Hartley et al.	Sep 2005	B2
6939371	Kugler et al.	Sep 2005	B2
6939377	Jayaraman et al.	Sep 2005	B2
6942691	Chuter	Sep 2005	B1
6942692	Landau et al.	Sep 2005	B2
6942693	Chouinard et al.	Sep 2005	B2
6945990	Greenean	Sep 2005	B2
6948017	Carpenter et al.	Sep 2005	B2
6951572	Douglas	Oct 2005	B1
6953475	Shaolian et al.	Oct 2005	B2
6955679	Hendricksen et al.	Oct 2005	B1
6955688	Wilson et al.	Oct 2005	B2
6960217	Bolduc	Nov 2005	B2
6962602	Vardi	Nov 2005	B2
6974471	Van Schie et al.	Dec 2005	B2
6981982	Armstrong et al.	Jan 2006	B2
6984244	Perez et al.	Jan 2006	B2
6989024	Hebert et al.	Jan 2006	B2
6989026	Richter et al.	Jan 2006	B2
6991639	Holman et al.	Jan 2006	B2
6994721	Israel	Feb 2006	B2
6994722	DiCarlo	Feb 2006	B2
7004926	Navia et al.	Feb 2006	B2
7004964	Thompson et al.	Feb 2006	B2
7004967	Chouinard et al.	Feb 2006	B2
7014653	Ouriel et al.	Mar 2006	B2
7022133	Yee et al.	Apr 2006	B2
7025773	Gittings et al.	Apr 2006	B2
7025779	Elliott	Apr 2006	B2
7029494	Soun et al.	Apr 2006	B2
7029496	Rakos et al.	Apr 2006	B2
7052511	Weldon et al.	May 2006	B2
7056323	Mareiro et al.	Jun 2006	B2
7074235	Roy	Jul 2006	B1
7074236	Rabkin et al.	Jul 2006	B2
7096554	Austin et al.	Aug 2006	B2
7101390	Nelson	Sep 2006	B2
7105015	Goshgarian	Sep 2006	B2
7105016	Shiu et al.	Sep 2006	B2
7105017	Kerr	Sep 2006	B2
7105020	Greenberg et al.	Sep 2006	B2
7118593	Davidson et al.	Oct 2006	B2
7122051	Dallara et al.	Oct 2006	B1
7122052	Greenhalgh	Oct 2006	B2
7125464	Chobotov et al.	Oct 2006	B2
7127789	Stinson	Oct 2006	B2
7131991	Zarins et al.	Nov 2006	B2
7137993	Acosta et al.	Nov 2006	B2
7144422	Rao	Dec 2006	B1
7160318	Greenberg et al.	Jan 2007	B2
7162302	Wang et al.	Jan 2007	B2
7163715	Kramer	Jan 2007	B1
7172577	Mangano et al.	Feb 2007	B2
7175651	Kerr	Feb 2007	B2
7175652	Cook et al.	Feb 2007	B2
7175657	Khan et al.	Feb 2007	B2
7189256	Smith	Mar 2007	B2
7189257	Schmitt et al.	Mar 2007	B2
7195648	Jones et al.	Mar 2007	B2
7201770	Johnson et al.	Apr 2007	B2
7220274	Quinn	May 2007	B1
7220275	Davidson et al.	May 2007	B2
7220276	Williams et al.	May 2007	B1
7229472	DePalma et al.	Jun 2007	B2
7232449	Sharkawy et al.	Jun 2007	B2
7235095	Haverkost et al.	Jun 2007	B2
7237552	Khera et al.	Jul 2007	B2
7241300	Sharkawy et al.	Jul 2007	B2
7241308	Andreas et al.	Jul 2007	B2
7244444	Bates	Jul 2007	B2
7261733	Brown et al.	Aug 2007	B1
7264631	DiCarlo	Sep 2007	B2
7264632	Wright et al.	Sep 2007	B2
7267685	Butaric et al.	Sep 2007	B2
7270675	Chun et al.	Sep 2007	B2
7285130	Austin	Oct 2007	B2
7294145	Ward	Nov 2007	B2
7297156	Nelson	Nov 2007	B2
7300454	Park et al.	Nov 2007	B2
7300460	Levine et al.	Nov 2007	B2
7306623	Watson	Dec 2007	B2
7309351	Escamilla et al.	Dec 2007	B2
7314481	Karpiel	Jan 2008	B2
7314483	Landau et al.	Jan 2008	B2
7316708	Gordon et al.	Jan 2008	B2
7320703	DiMatteo et al.	Jan 2008	B2
7331980	Dubrul et al.	Feb 2008	B2
7341598	Davidson et al.	Mar 2008	B2
7367980	Kida et al.	May 2008	B2
7367985	Mazzocchi et al.	May 2008	B2
7367986	Mazzocchi et al.	May 2008	B2
7371250	Mazzocchi et al.	May 2008	B2
7381216	Buzzard et al.	Jun 2008	B2
7402168	Acosta et al.	Jul 2008	B2
7402171	Osborne et al.	Jul 2008	B2
7407509	Greenberg et al.	Aug 2008	B2
7413560	Chong et al.	Aug 2008	B2
7413573	Hartley et al.	Aug 2008	B2
7419501	Chiu et al.	Sep 2008	B2
7425219	Quadri et al.	Sep 2008	B2
7435253	Hartley et al.	Oct 2008	B1
7438721	Doig et al.	Oct 2008	B2
7473271	Gunderson	Jan 2009	B2
7476244	Buzzard et al.	Jan 2009	B2
7481805	Magnusson	Jan 2009	B2
7491230	Holman et al.	Feb 2009	B2
7491232	Bolduc et al.	Feb 2009	B2
7520890	Phillips	Apr 2009	B2
7520895	Douglas et al.	Apr 2009	B2
7526849	Serrano	May 2009	B2
7527636	Dunfee et al.	May 2009	B2
7537606	Hartley	May 2009	B2
7553324	Andreas et al.	Jun 2009	B2
7572289	Sisken et al.	Aug 2009	B2
7575590	Watson	Aug 2009	B2
7578838	Melsheimer	Aug 2009	B2
7578841	Yadin et al.	Aug 2009	B2
7582111	Krolik et al.	Sep 2009	B2
7591832	Eversull et al.	Sep 2009	B2
7591843	Escano et al.	Sep 2009	B1
7611529	Greenberg et al.	Nov 2009	B2
7615072	Rust et al.	Nov 2009	B2
7618398	Holman et al.	Nov 2009	B2
7632299	Weber	Dec 2009	B2
7635382	Pryor	Dec 2009	B2
7635383	Gumm	Dec 2009	B2
7637932	Bolduc et al.	Dec 2009	B2
7641684	Hilaire et al.	Jan 2010	B2
7645298	Hartley et al.	Jan 2010	B2
7651519	Dittman	Jan 2010	B2
7666219	Rasmussen et al.	Feb 2010	B2
7670316	Windheuser et al.	Mar 2010	B2
7670369	Shaeffer et al.	Mar 2010	B2
7674284	Melsheimer	Mar 2010	B2
7678141	Greenan et al.	Mar 2010	B2
7691135	Shaolian et al.	Apr 2010	B2
7691139	Baker et al.	Apr 2010	B2
7695508	Van Der Leest et al.	Apr 2010	B2
7699885	Leonhardt et al.	Apr 2010	B2
7708771	Chuter et al.	May 2010	B2
7708773	Pinchuk et al.	May 2010	B2
7713261	Nash et al.	May 2010	B2
7717923	Kennedy, II et al.	May 2010	B2
7722657	Hartley	May 2010	B2
7736337	Diep et al.	Jun 2010	B2
7736383	Bressler et al.	Jun 2010	B2
7736384	Bressler et al.	Jun 2010	B2
7753951	Shaked et al.	Jul 2010	B2
7758625	Wu et al.	Jul 2010	B2
7758633	Nazzaro	Jul 2010	B2
7763063	Arbefeuille et al.	Jul 2010	B2
7766952	Horan et al.	Aug 2010	B2
7766961	Patel et al.	Aug 2010	B2
7771463	Ton et al.	Aug 2010	B2
7771465	Zukowski	Aug 2010	B2
7785340	Heidner et al.	Aug 2010	B2
7785361	Nikolchev et al.	Aug 2010	B2
7794473	Tessmer et al.	Sep 2010	B2
7799266	Parker et al.	Sep 2010	B2
7806917	Xiao	Oct 2010	B2
7815601	Jordan et al.	Oct 2010	B2
7815661	Mirizzi et al.	Oct 2010	B2
7828837	Khoury	Nov 2010	B2
7833202	Suzuki	Nov 2010	B2
7833259	Boatman	Nov 2010	B2
7837724	Keeble et al.	Nov 2010	B2
7842066	Gilson et al.	Nov 2010	B2
7846135	Runfola	Dec 2010	B2
7867267	Sullivan et al.	Jan 2011	B2
7867270	Hartley	Jan 2011	B2
7871419	Devellian et al.	Jan 2011	B2
7871430	Pavcnik et al.	Jan 2011	B2
7879081	DeMatteo et al.	Feb 2011	B2
7883537	Grayzel et al.	Feb 2011	B2
7892275	Hartley et al.	Feb 2011	B2
7892277	Douglas et al.	Feb 2011	B2
7909873	Tan-Malecki et al.	Mar 2011	B2
7914572	Hartley et al.	Mar 2011	B2
7922755	Acosta et al.	Apr 2011	B2
7935140	Griffin	May 2011	B2
7942924	Perez et al.	May 2011	B1
7993389	Globerman	Aug 2011	B2
8002814	Kennedy, II et al.	Aug 2011	B2
8021420	Dolan	Sep 2011	B2
8025692	Feeser	Sep 2011	B2
8034100	Shaolian et al.	Oct 2011	B2
8062344	Dorn et al.	Nov 2011	B2
8075607	Melsheimer	Dec 2011	B2
8075608	Gordon et al.	Dec 2011	B2
8092508	Leynov et al.	Jan 2012	B2
8118856	Schreck et al.	Feb 2012	B2
8147427	Nanto et al.	Apr 2012	B2
8152830	Gumm	Apr 2012	B2
8167892	Feller, III et al.	May 2012	B2
8182522	Sarac et al.	May 2012	B2
8216295	Benjamin et al.	Jul 2012	B2
8221494	Schreck et al.	Jul 2012	B2
8236040	Mayberry et al.	Aug 2012	B2
8343204	Osborne	Jan 2013	B2
8357192	Mayberry et al.	Jan 2013	B2
8491646	Schreck	Jul 2013	B2
8523931	Mayberry et al.	Sep 2013	B2
8568466	Shaolian et al.	Oct 2013	B2
8672989	Schreck et al.	Mar 2014	B2
8764812	Mayberry et al.	Jul 2014	B2
8808350	Schreck et al.	Aug 2014	B2
8821564	Schreck et al.	Sep 2014	B2
8828074	Xiao et al.	Sep 2014	B2
8844430	Mastropasqua et al.	Sep 2014	B2
8845708	Hartley et al.	Sep 2014	B2
8945202	Mayberry et al.	Feb 2015	B2
9149381	Schreck et al.	Oct 2015	B2
20010003161	Vardi et al.	Jun 2001	A1
20010014823	Ressemann	Aug 2001	A1
20010016767	Wilson et al.	Aug 2001	A1
20010025195	Shaolian et al.	Sep 2001	A1
20010027338	Greenberg	Oct 2001	A1
20010037142	Stelter et al.	Nov 2001	A1
20010039445	Hall et al.	Nov 2001	A1
20010049547	Moore	Dec 2001	A1
20020019660	Gianotti	Feb 2002	A1
20020029077	Leopold et al.	Mar 2002	A1
20020042650	Vardi et al.	Apr 2002	A1
20020049412	Madrid et al.	Apr 2002	A1
20020052648	McGuckin et al.	May 2002	A1
20020120322	Thompson et al.	Aug 2002	A1
20020123786	Gittings et al.	Sep 2002	A1
20020138088	Nash et al.	Sep 2002	A1
20020143383	Parodi	Oct 2002	A1
20020147491	Khan et al.	Oct 2002	A1
20020156516	Vardi	Oct 2002	A1
20020156518	Tehrani	Oct 2002	A1
20020173835	Bourang et al.	Nov 2002	A1
20020193806	Moenning et al.	Dec 2002	A1
20020193872	Trout et al.	Dec 2002	A1
20020198585	Wisselink	Dec 2002	A1
20030004560	Chobotov et al.	Jan 2003	A1
20030004561	Bigus et al.	Jan 2003	A1
20030028233	Vardi et al.	Feb 2003	A1
20030065386	Weadock	Apr 2003	A1
20030074043	Thompson	Apr 2003	A1
20030083678	Herweck et al.	May 2003	A1
20030083730	Stinson	May 2003	A1
20030083738	Holman et al.	May 2003	A1
20030093027	McGuckin, Jr.	May 2003	A1
20030097169	Brucker et al.	May 2003	A1
20030100943	Bolduc	May 2003	A1
20030125751	Griffin et al.	Jul 2003	A1
20030130721	Martin et al.	Jul 2003	A1
20030167060	Buzzard et al.	Sep 2003	A1
20030167083	Lashinski et al.	Sep 2003	A1
20030176910	Vrba et al.	Sep 2003	A1
20030225445	Derus et al.	Dec 2003	A1
20030236564	Majercak	Dec 2003	A1
20030236565	DiMatteo et al.	Dec 2003	A1
20030236566	Heuser	Dec 2003	A1
20040006380	Buck et al.	Jan 2004	A1
20040015150	Zadno-Azizi	Jan 2004	A1
20040039400	Schmieding et al.	Feb 2004	A1
20040044395	Nelson	Mar 2004	A1
20040049204	Harari et al.	Mar 2004	A1
20040049257	Kaspersen et al.	Mar 2004	A1
20040073288	Kerr	Apr 2004	A1
20040093058	Cottone et al.	May 2004	A1
20040098084	Hartley et al.	May 2004	A1
20040098096	Eton	May 2004	A1
20040106972	Deaton	Jun 2004	A1
20040111095	Gordon et al.	Jun 2004	A1
20040127975	Levine et al.	Jul 2004	A1
20040143312	Samson et al.	Jul 2004	A1
20040176832	Hartley et al.	Sep 2004	A1
20040193180	Buzzard et al.	Sep 2004	A1
20040193254	Greenberg et al.	Sep 2004	A1
20040215312	Andreas	Oct 2004	A1
20040215327	Doig et al.	Oct 2004	A1
20040225344	Hoffa et al.	Nov 2004	A1
20040230286	Moore et al.	Nov 2004	A1
20040230287	Hartley et al.	Nov 2004	A1
20040236403	Leonhardt et al.	Nov 2004	A1
20050015135	Shanley	Jan 2005	A1
20050021123	Dorn et al.	Jan 2005	A1
20050027305	Shiu et al.	Feb 2005	A1
20050027345	Horan et al.	Feb 2005	A1
20050033403	Ward et al.	Feb 2005	A1
20050033405	Solovay	Feb 2005	A1
20050038494	Eidenschink	Feb 2005	A1
20050038495	Greenan	Feb 2005	A1
20050049607	Hart et al.	Mar 2005	A1
20050049667	Arbefeuille et al.	Mar 2005	A1
20050049672	Murphy	Mar 2005	A1
20050049674	Berra et al.	Mar 2005	A1
20050049678	Cocks et al.	Mar 2005	A1
20050058327	Pieper	Mar 2005	A1
20050059923	Gamboa	Mar 2005	A1
20050059994	Walak et al.	Mar 2005	A1
20050060016	Wu et al.	Mar 2005	A1
20050060025	Mackiewicz et al.	Mar 2005	A1
20050060026	Gamboa	Mar 2005	A1
20050075647	Walters et al.	Apr 2005	A1
20050080476	Gunderson et al.	Apr 2005	A1
20050085845	Hilaire et al.	Apr 2005	A1
20050085891	Goto et al.	Apr 2005	A1
20050102018	Carpenter et al.	May 2005	A1
20050113693	Smith et al.	May 2005	A1
20050113853	Noriega et al.	May 2005	A1
20050113905	Greenberg et al.	May 2005	A1
20050119719	Wallace et al.	Jun 2005	A1
20050119731	Brucker et al.	Jun 2005	A1
20050121043	Abrams	Jun 2005	A1
20050121120	Van Dijk et al.	Jun 2005	A1
20050125002	Baran et al.	Jun 2005	A1
20050131517	Hartley et al.	Jun 2005	A1
20050131518	Hartley et al.	Jun 2005	A1
20050131519	Hartley	Jun 2005	A1
20050131526	Wong	Jun 2005	A1
20050149166	Schaeffer et al.	Jul 2005	A1
20050154441	Schaeffer et al.	Jul 2005	A1
20050154444	Quadri	Jul 2005	A1
20050159803	Lad et al.	Jul 2005	A1
20050165470	Weber	Jul 2005	A1
20050165480	Jordan et al.	Jul 2005	A1
20050171597	Boatman et al.	Aug 2005	A1
20050171598	Schaeffer	Aug 2005	A1
20050171599	White	Aug 2005	A1
20050177221	Mustapha	Aug 2005	A1
20050182476	Hartley et al.	Aug 2005	A1
20050215327	Weisel et al.	Sep 2005	A1
20050216043	Blatter et al.	Sep 2005	A1
20050222668	Schaeffer et al.	Oct 2005	A1
20050228480	Douglas et al.	Oct 2005	A1
20050240153	Opie	Oct 2005	A1
20050240255	Schaeffer	Oct 2005	A1
20050240258	Bolduc et al.	Oct 2005	A1
20050240260	Bolduc	Oct 2005	A1
20050246008	Hogendijk	Nov 2005	A1
20050273150	Howell et al.	Dec 2005	A1
20050288772	Douglas et al.	Dec 2005	A1
20060018948	Guire et al.	Jan 2006	A1
20060020320	Shaolian et al.	Jan 2006	A1
20060036315	Yadin et al.	Feb 2006	A1
20060052750	Lenker et al.	Mar 2006	A1
20060058864	Schaeffer et al.	Mar 2006	A1
20060089704	Douglas	Apr 2006	A1
20060095050	Hartley et al.	May 2006	A1
20060100658	Obana et al.	May 2006	A1
20060129223	Jabbour et al.	Jun 2006	A1
20060142704	Lentz	Jun 2006	A1
20060142838	Molaei et al.	Jun 2006	A1
20060149350	Patel et al.	Jul 2006	A1
20060155358	LaDuca et al.	Jul 2006	A1
20060155363	LaDuca et al.	Jul 2006	A1
20060155366	LaDuca et al.	Jul 2006	A1
20060161244	Sequin	Jul 2006	A1
20060173525	Behl et al.	Aug 2006	A1
20060178726	Myles	Aug 2006	A1
20060184226	Austin	Aug 2006	A1
20060184237	Weber et al.	Aug 2006	A1
20060200223	Andreas et al.	Sep 2006	A1
20060212107	Case et al.	Sep 2006	A1
20060217794	Ruiz et al.	Sep 2006	A1
20060224232	Chobotov	Oct 2006	A1
20060229669	Mirizzi et al.	Oct 2006	A1
20060229699	Tehrani et al.	Oct 2006	A1
20060229707	Khoury	Oct 2006	A1
20060233990	Humphrey et al.	Oct 2006	A1
20060233991	Humphrey et al.	Oct 2006	A1
20060247760	Ganesan et al.	Nov 2006	A1
20060247761	Greenberg et al.	Nov 2006	A1
20060259063	Bates et al.	Nov 2006	A1
20060264801	Bolling et al.	Nov 2006	A1
20060265045	Shiu et al.	Nov 2006	A1
20060271163	Shokoohi	Nov 2006	A1
20060271164	Shaolian et al.	Nov 2006	A1
20060276872	Arbefeuille et al.	Dec 2006	A1
20070005001	Rowe et al.	Jan 2007	A1
20070010867	Carter et al.	Jan 2007	A1
20070016280	Yacoby et al.	Jan 2007	A1
20070021828	Krolik et al.	Jan 2007	A1
20070027522	Chang et al.	Feb 2007	A1
20070027526	Demetriades et al.	Feb 2007	A1
20070043421	Mangiardi et al.	Feb 2007	A1
20070043425	Hartley et al.	Feb 2007	A1
20070043430	Stinson	Feb 2007	A1
20070049906	Magnusson	Mar 2007	A1
20070050006	Lavelle	Mar 2007	A1
20070050016	Gregorich et al.	Mar 2007	A1
20070055339	George et al.	Mar 2007	A1
20070055350	Erickson	Mar 2007	A1
20070055360	Hanson et al.	Mar 2007	A1
20070055362	Brown	Mar 2007	A1
20070060914	Magnusson	Mar 2007	A1
20070067019	Miller et al.	Mar 2007	A1
20070067023	Kveen et al.	Mar 2007	A1
20070073376	Krolik et al.	Mar 2007	A1
20070073388	Krolik et al.	Mar 2007	A1
20070088424	Greenberg et al.	Apr 2007	A1
20070112420	LaDuca	May 2007	A1
20070118207	Amplatz et al.	May 2007	A1
20070118208	Kerr	May 2007	A1
20070123805	Shireman et al.	May 2007	A1
20070142896	Anderson et al.	Jun 2007	A1
20070150051	Arnault De La Menardiere et al.	Jun 2007	A1
20070156224	Cioanta et al.	Jul 2007	A1
20070167926	Blott et al.	Jul 2007	A1
20070167955	Arnault De La Menardiere et al.	Jul 2007	A1
20070168014	Jimenez	Jul 2007	A1
20070168019	Amplatz et al.	Jul 2007	A1
20070173921	Wholey et al.	Jul 2007	A1
20070179592	Schaeffer	Aug 2007	A1
20070191927	Bowe et al.	Aug 2007	A1
20070198076	Hebert et al.	Aug 2007	A1
20070203571	Kaplan et al.	Aug 2007	A1
20070213804	Schaeffer et al.	Sep 2007	A1
20070213805	Schaeffer et al.	Sep 2007	A1
20070219620	Eells et al.	Sep 2007	A1
20070219621	Hartley et al.	Sep 2007	A1
20070225659	Melsheimer	Sep 2007	A1
20070225796	Yadin et al.	Sep 2007	A1
20070225797	Krivoruhko	Sep 2007	A1
20070225798	Gregorich	Sep 2007	A1
20070233220	Greenan	Oct 2007	A1
20070239254	Chia et al.	Oct 2007	A1
20070244540	Pryor	Oct 2007	A1
20070244542	Greenan et al.	Oct 2007	A1
20070244547	Greenan	Oct 2007	A1
20070248640	Karabey et al.	Oct 2007	A1
20070250084	Sharkway et al.	Oct 2007	A1
20070260301	Chuter et al.	Nov 2007	A1
20070260302	Igaki	Nov 2007	A1
20070260304	Gregorich et al.	Nov 2007	A1
20070149166	Schaeffer et al.	Dec 2007	A1
20070282166	Ayala et al.	Dec 2007	A1
20070282302	Wachsman et al.	Dec 2007	A1
20070293940	Schaeffer et al.	Dec 2007	A1
20070299494	Zukowski	Dec 2007	A1
20070299495	Zukowski et al.	Dec 2007	A1
20070299497	Shaolian et al.	Dec 2007	A1
20070299499	Hartley	Dec 2007	A1
20070299501	Hebert et al.	Dec 2007	A1
20080009932	Ta et al.	Jan 2008	A1
20080009933	Ta et al.	Jan 2008	A1
20080009937	Kipperman	Jan 2008	A1
20080015681	Wilson	Jan 2008	A1
20080027528	Jagger et al.	Jan 2008	A1
20080033354	Hartley et al.	Feb 2008	A1
20080033525	Shaked et al.	Feb 2008	A1
20080046005	Lenker et al.	Feb 2008	A1
20080046066	Jenson et al.	Feb 2008	A1
20080058918	Watson	Mar 2008	A1
20080065197	Meyer et al.	Mar 2008	A1
20080071343	Mayberry et al.	Mar 2008	A1
20080082052	Schnell et al.	Apr 2008	A1
20080082154	Tseng et al.	Apr 2008	A1
20080086191	Valencia	Apr 2008	A1
20080109065	Bowe	May 2008	A1
20080114444	Yu	May 2008	A1
20080114446	Hartley	May 2008	A1
20080125849	Burpee et al.	May 2008	A1
20080133000	Molony	Jun 2008	A1
20080140003	Bei et al.	Jun 2008	A1
20080167704	Wright et al.	Jul 2008	A1
20080167705	Agnew	Jul 2008	A1
20080172042	House	Jul 2008	A1
20080172119	Yamasaki et al.	Jul 2008	A1
20080172122	Mayberry et al.	Jul 2008	A1
20080188921	Yamasaki et al.	Aug 2008	A1
20080208319	Rabkin et al.	Aug 2008	A1
20080255652	Thomas et al.	Oct 2008	A1
20080262595	Chu et al.	Oct 2008	A1
20080262596	Xiao	Oct 2008	A1
20080269866	Hamer et al.	Oct 2008	A1
20080269867	Johnson	Oct 2008	A1
20080275542	LaDuca	Nov 2008	A1
20080281399	Hartley	Nov 2008	A1
20080294230	Parker	Nov 2008	A1
20080294237	Chu	Nov 2008	A1
20090005847	Adams	Jan 2009	A1
20090012602	Quadri	Jan 2009	A1
20090030495	Koch	Jan 2009	A1
20090043373	Arnault de la Menardiere et al.	Feb 2009	A1
20090043377	Greenberg et al.	Feb 2009	A1
20090048663	Greenberg	Feb 2009	A1
20090069880	Vonderwalde et al.	Mar 2009	A1
20090088791	Drasler et al.	Apr 2009	A1
20090099638	Grewe	Apr 2009	A1
20090099649	Chobotov et al.	Apr 2009	A1
20090105798	Koch	Apr 2009	A1
20090105806	Benjamin et al.	Apr 2009	A1
20090109065	Pinheiro	Apr 2009	A1
20090132024	Wolfgang Berkhoff	May 2009	A1
20090138065	Zhang et al.	May 2009	A1
20090155337	Schreck et al.	Jun 2009	A1
20090164001	Biggs et al.	Jun 2009	A1
20090192586	Tabor et al.	Jul 2009	A1
20090240316	Bruszewski	Sep 2009	A1
20090254165	Tabor et al.	Oct 2009	A1
20090254170	Hartley et al.	Oct 2009	A1
20090259290	Bruszewski et al.	Oct 2009	A1
20090259296	McIff et al.	Oct 2009	A1
20090264985	Bruszewski	Oct 2009	A1
20090276028	Bailey et al.	Nov 2009	A1
20090287145	Cragg et al.	Nov 2009	A1
20100016943	Chobotov	Jan 2010	A1
20100160863	Heuser	Jan 2010	A1
20100030318	Berra	Feb 2010	A1
20100057185	Melsheimer et al.	Mar 2010	A1
20100063575	Shalev et al.	Mar 2010	A1
20100063576	Schaeffer et al.	Mar 2010	A1
20100094390	Goldmann et al.	Apr 2010	A1
20100094393	Cordeiro et al.	Apr 2010	A1
20100114290	Rasmussen et al.	May 2010	A1
20100168619	Elsesser	Jul 2010	A1
20100168674	Shaw et al.	Jul 2010	A1
20100168834	Ryan et al.	Jul 2010	A1
20100179635	Dittman	Jul 2010	A1
20100179636	Mayberry et al.	Jul 2010	A1
20100179638	Shaolian et al.	Jul 2010	A1
20100261662	Schreck et al.	Oct 2010	A1
20100262157	Silver et al.	Oct 2010	A1
20100268234	Aho et al.	Oct 2010	A1
20100274270	Patel et al.	Oct 2010	A1
20100274340	Hartley et al.	Oct 2010	A1
20100318181	Shaolian et al.	Dec 2010	A1
20110009945	Parker et al.	Jan 2011	A1
20110015728	Jimenez et al.	Jan 2011	A1
20110046712	Melsheimer et al.	Feb 2011	A1
20110054586	Mayberry et al.	Mar 2011	A1
20110054587	Mayberry et al.	Mar 2011	A1
20110121023	Milan	May 2011	A1
20110178588	Haselby	Jul 2011	A1
20110218607	Arbefeuille et al.	Sep 2011	A1
20110218617	Nguyen et al.	Sep 2011	A1
20110224742	Weisel et al.	Sep 2011	A1
20110224772	Mayberry et al.	Sep 2011	A1
20110224782	Douglas et al.	Sep 2011	A1
20110251664	Acosta De Acevedo	Oct 2011	A1
20110257718	Argentine	Oct 2011	A1
20110270371	Argentine	Nov 2011	A1
20110282425	Dwork	Nov 2011	A1
20110288627	Hartley et al.	Nov 2011	A1
20110313503	Berra et al.	Dec 2011	A1
20120029610	Shaolian et al.	Feb 2012	A1
20120109279	Mayberry	May 2012	A1
20120221007	Batten et al.	Aug 2012	A1
20120239003	Julson et al.	Sep 2012	A1
20120277847	Benjamin	Nov 2012	A1
20130184805	Sawada	Jul 2013	A1
20130281787	Avneri et al.	Oct 2013	A1
20140194970	Chobotov	Jul 2014	A1
20140249615	Schreck	Sep 2014	A1
20140350658	Benary et al.	Nov 2014	A1
20140358214	Schreck et al.	Dec 2014	A1
20150173932	Mayberry	Jun 2015	A1
20150190615	Shaltis	Jul 2015	A1
20150366688	Schreck	Dec 2015	A1

Foreign Referenced Citations (129)

Number	Date	Country
2007648	Apr 1991	CA
2127458	Jul 1993	CA
2133530	Apr 1995	CA
2220141	Nov 1996	CA
2287406	Dec 1997	CA
105232195	Jan 2016	CN
295 21 548	Feb 1995	DE
295 21 776	Feb 1995	DE
100 17 147	Oct 2001	DE
0 282 175	Sep 1988	EP
0 323 176	Jul 1989	EP
0 177 330	Jun 1991	EP
0 458 568	Nov 1991	EP
0 564 373	Oct 1993	EP
0 596 145	May 1994	EP
0 621 015	Oct 1994	EP
0 659 389	Jun 1995	EP
0 688 545	Dec 1995	EP
0 689 806	Jan 1996	EP
0 712 614	May 1996	EP
0 732 088	Sep 1996	EP
0 732 089	Sep 1996	EP
0 740 928	Nov 1996	EP
0 747 020	Dec 1996	EP
0 775 470	May 1997	EP
0 782 841	Jul 1997	EP
0 783 873	Jul 1997	EP
0 783 874	Jul 1997	EP
0 875 262	Nov 1998	EP
0 880 938	Dec 1998	EP
0 880 948	Dec 1998	EP
0 904 745	Mar 1999	EP
0 696 447	Jan 2000	EP
0 974 314	Jan 2000	EP
1 358 903	Nov 2003	EP
1 433 438	Jun 2004	EP
1 470 797	Oct 2004	EP
1 508 313	Feb 2005	EP
1 935 374	Jun 2008	EP
2 429 452	Mar 2012	EP
2 635 241	Sep 2013	EP
2 680 915	Jan 2014	EP
1 038 606	Jul 1998	ES
1 193 759	Jun 1970	GB
2206118	Sep 1990	GB
04-25755	Jan 1992	JP
H05-81257	Nov 1993	JP
30-09638	Apr 1994	JP
07-047134	Feb 1995	JP
08-052165	Feb 1996	JP
08-336597	Dec 1996	JP
H951954	Feb 1997	JP
09-164209	Jun 1997	JP
9-511160	Nov 1997	JP
2000-500047	Jan 2000	JP
2004-130068	Apr 2004	JP
2004-136065	May 2004	JP
2004-532680	Oct 2004	JP
2007-236472	Sep 2007	JP
5629871	Oct 2014	JP
WO 9014054	Nov 1990	WO
WO 9313825	Jul 1993	WO
WO 9424961	Nov 1994	WO
WO 9521592	Aug 1995	WO
WO 9614808	May 1996	WO
WO 9634580	Nov 1996	WO
WO 9638101	Dec 1996	WO
WO 9639999	Dec 1996	WO
WO 9641589	Dec 1996	WO
WO 9710757	Mar 1997	WO
WO 9710777	Mar 1997	WO
WO 9714375	Apr 1997	WO
WO 9717911	May 1997	WO
WO 9718006	May 1997	WO
WO 9719652	Jun 1997	WO
WO 9726936	Jul 1997	WO
WO 97033532	Sep 1997	WO
WO 97045072	Dec 1997	WO
WO 9802100	Jan 1998	WO
WO 9811846	Mar 1998	WO
WO 9820812	May 1998	WO
WO 9827894	Jul 1998	WO
WO 9827895	Jul 1998	WO
WO 9853761	Dec 1998	WO
WO 9913808	Mar 1999	WO
WO 99029262	Jun 1999	WO
WO 9944536	Sep 1999	WO
WO 9947077	Sep 1999	WO
WO 9953865	Oct 1999	WO
WO 9958084	Nov 1999	WO
WO 0033769	Jun 2000	WO
WO 0053251	Sep 2000	WO
WO 0067674	Nov 2000	WO
WO 0078248	Dec 2000	WO
WO 0103762	Jan 2001	WO
WO 0124732	Apr 2001	WO
WO 0126707	Apr 2001	WO
WO 01067993	Sep 2001	WO
WO 0236179	May 2002	WO
WO 0239888	May 2002	WO
WO 02060345	Aug 2002	WO
WO 03068302	Aug 2003	WO
WO 03094796	Nov 2003	WO
WO 04047885	Jun 2004	WO
WO 04089249	Oct 2004	WO
WO 04105693	Dec 2004	WO
WO 05037076	Apr 2005	WO
WO 05037141	Apr 2005	WO
WO 05067819	Jul 2005	WO
WO 06028925	Mar 2006	WO
WO 06036690	Apr 2006	WO
WO 06047708	May 2006	WO
WO 06071915	Jul 2006	WO
WO 06117321	Nov 2006	WO
WO 07027830	Mar 2007	WO
WO 07092276	Aug 2007	WO
WO-2008002426	Jan 2008	WO
WO 08034106	Mar 2008	WO
WO 08083767	Jul 2008	WO
WO 08086084	Jul 2008	WO
WO-2008143243	Nov 2008	WO
WO 09000546	Dec 2008	WO
WO 09023221	Feb 2009	WO
WO 09105699	Aug 2009	WO
WO 10127040	Nov 2010	WO
WO 11049808	Apr 2011	WO
WO 12061526	May 2012	WO
WO 12118901	Sep 2012	WO
WO-2014159116	Oct 2014	WO

Non-Patent Literature Citations (12)

Entry
US 5,690,647 A, 11/1997, Osborne (withdrawn)
US 6,413,270 B1, 07/2002, Thornton et al. (withdrawn)
Chinese Office Action dated Sep. 28, 2018, from application No. 201680001552.1.
Extended European Search Report dated Jan. 9, 2018, from application No. 16790254.3.
Chinese Office Action dated Jun. 3, 2019, for application No. 201680001552.1.
U.S. Appl. No. 09/714,854, filed Nov. 15, 2000, Shaolian et al.
Definition of mounted, Dictionary.com, retrieved Nov. 18, 2010 from http://dictionary.com/browse/mounted.
Instructions for use of the Gore Excluder® AAA Prosthesis, pp. 1-17, Apr. 2009.
International Search Report and Written Opinion, re PCT Application No. PCT/US 16/40197, dated Oct. 24, 2016.
Minion et al., “Technique of slow deployment of Gore Excluder endograft improves accuracy of placement”, J Vasc Surg 43:852-4, 2006.
Japanese Office Action dated Jun. 30, 2020, from application No. 2016-565006.
Japanese Office Action dated Jun. 1, 2021, from application No. 2016-565006.

Related Publications (1)

	Number	Date	Country
	20180177622 A1	Jun 2018	US

Provisional Applications (1)

	Number	Date	Country
	62187103	Jun 2015	US

Locking assembly for coupling guidewire to delivery system

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

CPC

International Classifications

Abstract